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Ab Antibody 
APC  
AP1 
Antigen presenting cell  
Adaptor Protein 1 
BSA  Bovine serum albumin 
CD 
CHX 
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CMA 
CRAC current 
Cluster of differentiation 
Cycloheximide 
Chinese hamster ovary cells 
Conconamycin A 
Calcium release-activated calcium current 
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Ctrl- 
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Cytotoxic T-Lymphocyte antigen 4 
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cSMAC  Central supra-molecular activation complex  
DG Diacylglycerol 
dSMAC  Distal supra-molecular activation complex  
DISC Death Inducing Signalling Complex 
EEA1 Early Endosome Autoantigen 1 
ER Endoplasmic reticulum 
ELISA  
FACS 
Enzyme-linked immunosorbent assay 
Fluorescence-activated cell sorting  
FCS  Fetal calf serum  
FHL  Familial hemophagocytic lymphohistiocytosis  
GTPase Gaunosine triphoshatase 
HBSS  Hank's balanced salt solution  
HEPES  N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid,  
IP3 Inositol trisphosphate 
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     IS 
JACoP 
Immunoreceptor tyrosine-based activating motif 
Immunological synapse  
Just Another Colocalization plugin 
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MHC 
MTOC 
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PBMCs 
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SE 
si-RNA 
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Stx 
TCR 
TGN 
Tc 
Th 
Treg 
VAMP 
Lysosomal associated membrane protein  
Lactate dehydrogenase 
Lymphocyte function-associated antigen 1 
Leucocyte reduction chamber 
Major histocompatibility complex 
Microtubule organization centre 
Natural killer cells 
Natural killer T cells 
Normal rat kidney epithelial 
Normal rat liver 
N-ethylamide sensitive factor 
Pheripheral blood mononuclear cells 
Pheripheral supra-molecular activation complex 
Room temperature 
Sodium dodecyl sulphate 
Staphylococcal enterotoxins 
small interfering RNA 
Soluble NSF Attachment Protein 
Soluble N-ethylmaleimide sensitive factor Attachment 
protein Receptors 
Syntaxin 
T cell receptor 
Trans Golgi network 
T cytotoxic cell 
T helper cell 
T regulatory cell 
Vesicle associated membrane protein 
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ZUSAMMENFASSUNG 
 
Zytotoxische T-Lymphozyten (CTL) sind die CD8
+ 
T-Effektor-Lymphozyten des 
Immunsystems, welche Zellen, die entweder mit Pathogenen infiziert sind, 
Tumorzellen darstellen oder als Nicht-selbst erkannt wurden, identifizieren und töten, 
ohne benachbarte gesunde Zellen zu schädigen. Dies wird durch die spezifische 
Freisetzung zytotoxischer Moleküle an der immunologischen Synapse (IS), einer 
engen Kontaktstelle zwischen CTL und Zielzelle, erreicht. Soluble N-
ethylmaleimide-sensitive-factor attachment receptor (SNARE)-Komplexe und 
SNARE-Komplex-verwandte Proteine, die an dem Signalweg des Vesikeltransports 
beteiligt sind, wurden auch eine Beteiligung beim Sortieren und beim Transport der  
lytischen Granula spezifisch zur IS hin zugesprochen. 
Die Untersuchung des Expressionsmusters verschiedener SNARE-Proteine in 
primären humanen CTL hat gezeigt, dass Syntaxin 8 sowohl in naiven als auch in 
aktivierten CD8
+
 T-Zellen sehr hoch exprimiert ist. Zusätzlich war Syntaxin 8 eines 
der untersuchten SNARE-Proteine, das zu einen hohen Anteil mit lytischen Granula 
in CTL kolokalisiert war 
1
. Aktuell werden Qa-, Qb- und R-SNARE, aber bisher kein 
Qc-SNARE, mit Funktionen von CTL in Zusammenhang gebracht. Daher wird in 
dieser Arbeit der Fokus auf Syntaxin 8 liegen, da Syntaxin 8, ein Qc-SNARE, an der 
IS akkumuliert und teilweise mit lytischen Granula kolokalisiert, was für eine 
möglicherweise wichtige Rolle in der Funktion von CTL sprechen kann. Somit haben 
wir uns das Ziel gesetzt, die Bedeutung von Syntaxin 8 bei der Zytotoxizität humaner 
CTL zu untersuchen. Unsere Untersuchungen weisen darauf hin, dass Syntaxin 8 am 
Transportweg der Endosomen beteiligt ist, was durch die  Kolokalisation mit frühen 
Endosomen (teilweise), späten, Recycling- und lysomalen Kompartimenten, vor allen 
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Dingen aber mit späten und Recycling-Endosomen, unterstützt wird. Einhergehend 
mit einer effizienten Herunterregulation von Syntaxin 8 haben wir eine reduzierte 
Zytotoxizität in CTL beobachtet, die mit Hilfe eines Zytotoxizitätsassays in Echtzeit 
gemessen wurde. Weiterhin konnten wir mittels eines ELISA für Perforin zeigen, 
dass die verminderte Zytotoxozität durch Syntaxin 8 Herunterregulation nicht durch 
eine verminderte Exozytose (von Perforin) bedingt wird, sondern vorangegangene 
Prozesse, die zu einer verspäteten Freisetzung von Perforin oder lytischer Granula 
führen können, betroffen sind. Diese vorangegangenen Prozesse können zum einen 
die Generierung zytotoxischer Moleküle sein, zum anderen können sie aber auch das 
Sortieren und den Transport zytotoxischer Moleküle in zur Freisetzung bereite 
lytische Granula hin zur IS der CTL betreffen. Die Behandlung mit Cycloheximid 
von Kontroll- und Syntaxin 8 herunterregulierten CTL weist darauf hin, dass  
Mechanismen betroffen sind, die zeitlich nach der Proteinsynthese liegen. Da die 
Zytotoxizität zu späteren Zeitpunkten in den Syntaxin 8 herunterregulierten Zellen 
sich unter DMSO leicht erhöht hat (was in den mit Cyclohexamid behandelten 
Syntaxin 8 herunterregulierten Zellen nicht beobachtet wurde), kann man davon 
ausgehen, dass die Sortierung und Ausschüttung der zytotoxischen Moleküle an der 
IS beeinflusst ist, schließt aber nicht die Möglichkeit aus, dass Syntaxin 8 die 
Generierung der zytotoxischen Moleküle beeinflusst. FACS Analysen haben gezeigt, 
dass sich der Perforin-Gehalt zwischen Kontroll- und Syntaxin 8 herunterregulierten 
CTL, die mit Zielzellen in Kontakt gebracht wurden, zu unterschiedlichen 
Zeitpunkten nicht unterschieden hat. Dennoch haben wir eine generelle Tendenz zu 
einem erhöhten Perforin-Gehalt in Kontroll-CTL beobachtet. Die Untersuchung von 
mit Zielzellen konjugierten CTL mittels Immunzytochemie und hochauflösenden 
bildgebenden Verfahren (mit Hilfe von Auflichtfluoreszenzmikroskopie und 
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anschließender Dekonvolution) zu unterschiedlichen Zeitpunkten hat gezeigt, dass die 
Akkumulation des T-Zell-Rezeptors (TZR) und der lytischen Granula nur nach zwei 
Stunden Konjugation in Syntaxin 8 herunterregulierten Zellen beeinträchtigt war. 
Syntaxin 8 herunterregulierte Zellen verfügten im Vergleich zu Kontroll-Zellen über 
größere Tropfen-ähnliche Perforin enthaltende Vesikel, ein Hinweis darauf, dass 
Perforin schon in der frühen Phase der Sortierung zurückbleibt, wahrscheinlich in 
Kompartimenten des trans-Golgi-Netzwerkes. Diese Verzögerung beim Sortieren und 
Verteilen in Syntaxin 8 herunterregulierten Zellen mag der Grund dafür sein, dass 
lytische Granula zwar die IS erreichen, dort aber sehr langsam freigesetzt werden im 
Vergleich zu den Kontrollzellen und damit eine verminderte Zytotoxizität 
hervorrufen. Wenn Syntaxin 8 herunterregulierte CTL im Vergleich zu Kontrollzellen 
eine verminderte Zytotoxizität zeigen,  haben wir zu späteren Zeitpunkten eine 
langsamere Degradation des TZR in diesen Zellen im Vergleich zu Kontrollzellen 
gefunden. Aber auch wenn das Recycling des TZR zur Plasmamembran vielleicht 
langsamer ist, so ist die Bildung der IS in Syntaxin 8 herunterregulierten Zellen nicht 
vermindert. Aus diesem Grunde machen Syntaxin 8 herunterregulierte CTL normale 
Kontakte mit Zielzellen, zeigen eine nicht beeinträchtigte Exozytose, aber weisen 
eine verminderte oder verzögerte Sortierung bzw. einen verminderten oder 
verzögerten Transport zytotoxischer Moleküle in zur Freisetzung fähige lytische 
Granula auf. Demnach reguliert Syntaxin 8 die Zytotoxizität von CTL durch den 
Einfluss auf das Sortieren und Verteilen der zytotoxischen Moleküle durch den 
Reifungsweg der Endosomen.  
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1. INTRODUCTION 
 
1.1. Immune system 
All living organisms have their own defense mechanisms to survive against foreign 
invaders. The higher the organism is, in the evolutionary tree, more evolved is its 
defense mechanism executed by its immune system. Single cell prokaryotes like 
bacteria have rudimentary defense mechanisms such as secretion of certain enzymes 
targeting viruses and also CRISPRs (Cluster Regularly Interspaced Short Palindromic 
Repeats) which have partial palindromic repeats separated by short stretches of DNA 
called spacers, acquired from extrachromosomal elements like viral genetic materials 
which are also cleaved by these CRISPRs 
2
. Primitive eukaryotes, plants, insects and 
primitive chordates have slightly evolved immune systems involving phagocytosis, 
complement system and production of anti-microbial peptides. In mammals the 
immune system is more extensive and highly evolved consisting of a dynamic 
network of cells and molecules acting together to identify and eliminate foreign 
particles, pathogens, cancerous cells or mutated self cells. Immune system in 
mammals can be classified into innate immunity and adaptive immunity. Innate 
immunity is an organism’s first line of defense. It has broad reactivity and is not 
specific for a particular pathogen. It includes physical barriers like skin, mucus 
membrane, tears; components of complement system, cytokines and cells like 
macrophages, neutrophils, eosinophils, basophils and also natural killer (NK) cells. 
On encountering an infection, components of the innate immune system initially 
induce inflammation and vasodilation by release of chemicals like histamine, the 
components of the complement system, which in turn mobilize the immune cells like 
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macrophages, NK cells, dendritic cells, neutrophils and other leukocytes to 
phagocytose the pathogen at the site of the inflammation 
3
. Recently the evidences 
emerged show that NK cells are also part of adaptive immune response as they are 
known to posses antigen specific immune memory and can respond to secondary 
infections by the same antigen 
4,5
. On the other hand, adaptive immune responses are 
highly specific, as every antigen is distinguished and selectively eliminated. Another 
significant feature of adaptive immunity is its immunological memory which 
facilitates the system to react rapidly to antigens on its second encounter, thus 
providing lifelong immunity against many antigens. The ability of adaptive immune 
system to recognize self and non-self cells is essential to eliminate foreign antigens 
without harming the self cells. 
 
1.2. Cell mediated and humoral immunity 
Adaptive immunity consists of cell-mediated and humoral immune responses. B 
lymphocytess and T lymphocytes are the main components of cell-mediated immunity 
and soluble immunoglubulins (antibodies) secreted by B lymphocytes majorly consist 
the humoral immunity 
6
. 
B lymphocytes mature within the bone marrow, express and secrete antibodies which 
are specific and unique for each antigen. Antibodies are glycoproteins with antigen 
binding sites which can bind specifically to its corresponding antigenic epitopes. 
When naïve B cells come in contact with an antigen, they proliferate rapidly and 
mature into effector cells also called as plasma cells (that rapidly secrete huge amount 
antibodies which neutralize the antigen) and memory cells. This antigen specific 
immune memory is preserved in the memory cells which live longer than the naïve 
cells 
7
. Such antibodies are functional components of humoral immunity. 
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T lymphocytes are another main aspect of cell-mediated immunity. Like B 
Lymphocytes, T lymphocytes also originate in the bone marrow but they mature in 
thymus. Unlike B cells, T cells can recognize antigens only when they are processed 
and presented as antigenic peptides by special receptors called major 
histocompatibility complex (MHC) molecules expressed on cell membranes. The two 
major variants of MHC molecules that are expressed in mammals are MHC class I 
and class II variants. MHC class I is expressed by almost all types of cells in the body 
and composes of a heavy chain linked to β2 – microglobulin. Whereas MHC class II 
is expressed by antigen presenting cells and is made up of alpha and beta subunits 
8
. 
The T cell receptors (TCR) expressed by T cells identify and bind to the antigenic 
peptides bound to the MHC molecules. This stimulates the T cells and causes them to 
proliferate and mature into effector and memory T cells. T cells can be classified into 
four main types. T Helper (Th) cells , T Cytotoxic (Tc) cells, Natural killer T  (NKT) 
cells and γδ T cells 9. Th cells are also called as CD4+ T cells and Tc cells as CD8+ T 
cells as they have CD4 (Cluster of Differentiation 4) and CD8 co-receptors 
respectively. A subpopulation of these cells develop into regulatory T cells (Tregs) or 
suppressor T cells (Ts) which help in the immune cell homeostasis 
10-12
. CD4
+
 and 
CD8
+
 cells on coming in contact with the immunogen, mature into effector cells and 
later into memory T cells 
13
. Th (CD4
+
) cells recognize and bind to antigenic peptides 
presented on MHC class II molecules. This brings about stimulation of the CD4
+
 cells 
causing them to proliferate and stimulate cytokines like IL-2, IL-4, IL-10, INF-γ etc. 
These cytokines in turn induce the activation and proliferation of B lymphocytes, Tc 
cells, macrophages and other components of the immune system 
14
. 
Tc cells or CD8
+
 T cells recognize and interact with antigenic peptides presented on 
MHC class I molecules via T cell receptors (TCR) 
15
. This interaction stimulates and 
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activates these CD8
+
 cells to mature into effector T cells and later into memory cells 
13,16
. Such activated effector CD8
+
 T cells are also called as Cytotoxic T Lymphocytes 
(CTLs), as they kill the target cells via release of cytotoxic molecules. These target 
cells are the cells which are pathogen infected cells or tumor cells or foreign cells 
from graft tissues. Memory T cells have longer life span and can be easily activated 
and converted to effector memory T cells which are cytotoxic and are capable of 
killing their targets 
17
. 
 
1.3. Cytotoxic T Lymphocytes (CTLs) 
The effector CD8
+
 T cells or CTLs and also NK cells are known to kill their targets 
by two major pathways, by secretion of lytic granules containing perforin and 
granzymes and by expression of FAS ligands 
18-21
 (Fig. 1). Another mechanism of 
killing mostly used by activated macrophages, NK cells and CD4
+
 T cells is through 
TNF-α mediated cytokine pathway 22,23 but it is not yet clear if it is used as a killing 
mechanism by CTLs though TNF-α expression increases on activation of CD8+ T 
cells 
23,24
. CTLs form with their cognate target cells a tight junction, called the 
immunological synapse (IS), where they specifically release their cytotoxic molecules 
to kill the target cells, without harming the healthy bystander cells. One CTL or NK 
cell can kill more than one target cell either simultaneously and/or consecutively 
25
. 
The effector CD8
+
 T cells recognize peptides presented by MHC I molecules on 
target cells to form conjugates and finally kill the target cells. Endogenous proteins or 
peptides expressed in virus infected or cancerous cells are cleaved to smaller peptides 
in organelles called proteosomes. Such peptides are then bound to MHC I molecules 
assembled in rough (ER) endoplasmic reticulum. These peptide MHC I complexes are 
transported to the plasma membrane of these altered target cells, which are then 
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identified by TCR complexes of the CD8
+
 T cells. CD8
+
 T cells can be activated in 
vitro by an artificial stimulation with superantigens derived from Staphylococcus 
aureus. Such superantigens are called Staphylococcal Enterotoxins A, B, E (SEA, 
SEB and SEE). These superantigens are not expressed as processed peptides on MHC, 
but they bind to MHC class II molecule at a region distinct from its antigenic peptide 
binding site and interact with CD8 or CD4 co-receptors of the T cells 
26-28
. 
 
1.3.1. T Cell Receptor complex 
TCR complex is the functional unit of the T cells responsible for the recognition of 
the processed antigens leading to the activation of the T cells. They can recognize 
only processed antigenic peptides expressed on MHC molecules of the target cells. In 
CD8
+
 T cells, the TCR and its CD8 co-receptor recognize and bind to the antigen 
MHC class I complex. Once they recognize and bind to the antigenic complex, 
another important component of the TCR complex called the CD3 molecules, which 
have intracellular domains, transduce the signals to other signalling molecules leading 
to T cell activation. Most T cells have αβTCR where a membrane bound 
immunoglobulin-like heterodimer TCR is made of disulphide bonded α and β chains. 
These are the antigen binding units of the TCR complex 
29
. 
Around 5 % of T cells have been shown to express γδTCR which can recognize and 
bind to non classical MHC molecules or directly to pathogen glycoproteins 
30
. 
The CD3 receptor which is another functional unit of the TCR complex is composed 
of CD3γε, CD3δε subunits and CD3δδ chains 31. 
When the TCR identifies and binds to the antigen-MHC complex, there is clustering 
of the CD8 co-receptors which causes the Lck bound to the cytoplasmic tail of the 
CD8 co-receptor to phosphorylate the immunoreceptor Tyrosine- based activation 
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motifs (ITAMs) found on the cytoplasmic tails of the CD3 co-receptors 
32
. These 
phosphorylated tyrosine motifs become docking sites for downstream effector 
molecules such as ZAP-70, a tyrosine kinase, which further phosphorylates SLP-76 
and LAT. These phosphorylated SLP-76 and LAT serve as docking elements for 
numerous cytoplasmic signalling molecules including Grb2, Vav (triggering 
Ras/MAP (Mitogen Activated Protein) kinase pathway), PLC-γ1 or PI3-kinase 33. The 
PLC1 γ derived calcium signalling is crucial for normal T cell functioning. Activated 
PLC1 γ generates second messengers Inositol trisphosphate (IP3) and Diacylglycerol 
(DG) by cleaving PIP2. IP3 then facilitates active depletion of ER Ca
2+
 stores which 
mediates ORAI mediated CRAC currents causing Ca
2+
 influx into the T cell 
34-36
. Ca
2+
 
influx and maintenance of elevated levels of [Ca
2+
]i is then brought about by the 
mitochondrial Ca
2+
 uptake 
37
. Ca
2+
 is necessary for many T cell functions like T cell 
activation, cytotoxicity, activation of transcription factors that bring about 
proliferation of the T cell and also production of cytokines like IL-2 
38
.  
 
1.3.2. Immunological Synapse 
Activation of the T cells promotes the polarization of the T cell by movement of the 
microtubule organization centre (MTOC) to the junction where the CTL conjugates 
with the target cell 
39
. This junction is termed as an immunological synapse (IS) (Fig. 
1). TCR accumulation and MTOC movement is said to be essential for the formation 
of a functional IS. The IS has been divided into different domains: the central 
Supramolecular Activation Complex (cSMAC), peripheral Supramolecular Activation 
Complex (pSMAC) and the distal Supramolecular Activation Complex (dSMAC) 
40
. 
The cSMAC is the central region containing the TCR MHC-antigen complex, CD28, 
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CD8 coreceptors along with signalling molecules like Lck, PKCθ. Surrounding this 
region is the pSMAC which consists of the adhesion molecules, like Lymphocyte 
Function-associated Antigen 1 (LFA1), and a cytoskeletal protein called talin, which 
can link the intergrins to actin cytoskeleton 
41
. During the formation of the IS, the 
actin filaments of CTL cytoskeleton rearrange themselves towards the outermost part 
of the IS called the dSMAC 
40
. It has been reported that the lytic granules move along 
the microtubules after the MTOC polarization, to be secreted at the IS 
42,43
. It has also 
been shown that the strength of the TCR signals effect the lytic granule accumulation 
but not the MTOC polarization to the IS, meaning that the lytic granule polarization 
and centrosome (MTOC) polarization are independently regulated with respect to the 
strength of the TCR signals 
44
. It has been further proven that the enrichment, docking 
and release of the lytic granules at the IS is dependent on its tethering with CD3 
endosomes and that the Qb-SNARE protein Vti1b facilitates this tethering process 
45
. 
When the lytic granules are tethered with the CD3 endosomes, their dwell time at the 
IS increases leading to their release at the IS 
45
. 
 
1.3.3. Lytic granules, the secretory lysosomes in immune cells 
As mentioned earlier, lytic granules, also termed cytotoxic granules, are involved in 
one of the main mechanisms by which the CTLs and NK cells kill their targets. Lytic 
granules are modified lysosomes called as secretory lysosomes that undergo regulated 
secretion in response to some external stimuli like the activated TCR signaling in 
CTLs. Such a secretion is induced by the clustering of lytic granules around the 
polarized MTOC 
42,43
. It has also been shown that a protein called Vti1b tethers the 
lytic granules to the TCR to facilitate lytic granule secretion 
45
. 
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These are acidic vesicles which contain cytotoxic proteins such as, pore forming 
protein called perforin, proteoglycans like Chondroitin sulphate A, different varieties 
of serine proteases called granzymes and different other lysosomal enzymes such as 
Carboxypeptidase A 
46
. The core of the lytic granules have Mannose 6-phosphate 
receptors, so that the granzyme A and B which have Mannose 6-phosphate residues 
are targeted and concentrated to the lytic granules 
47
. These cytotoxic molecules are 
stored in their inactive form in these lytic granules by their acidic environment (pH 
4.5 – 5.5). Once these molecules are released out of their acidic environment they are 
converted to their lethal active cytolytic form. Apart from the cytotoxic molecules, 
lytic granules contain lysosomal transmembrane proteins like CD63, lysosomes 
associated membrane proteins (Lamp1 and Lamp2) and other soluble proteins like 
cathepsins 
48
. 
 
1.3.3.1. Perforin 
Perforin is a pore forming glycoprotein present in the lymphocyte lytic granules. The 
native 70 kDa form of perforin, when synthesised is made up of 555 amino acids, 
starting with a signal peptide of 21 amino acids that is cleaved off when the native 
form is transferred from ER to the lytic granules, to become a 534 amino acid mature 
60 kDa form 
49
. Approximately 280 amino acids present in the centre of the perforin 
molecule are highly conserved and homologous to those present in complement 
protein C9. Both have a conserved domain from aminoacid 191 – 211 (called LB) 
which have been known to form α helix that interact with the lipid bilayer 46. Another 
feature common in both perforin and C9 protein is that they both do not have the TPS 
(Thrombospodin) domain which is present at the amino terminus of all other 
complement proteins. The absence of this domain is believed to account for their 
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ability to form circular polymers 
50
. The carboxy C2 domain of mature perforin, 
facilitates the insertion of perforin into the target cell plasma membrane 
49
.  
Once the perfroin reaches the lytic granules, the acidic environment of these granules 
favours the interaction of active perforin with proteoglycans to render perforin 
inactive and harmless to the organelle, thus making it possible for lytic granules to 
store active perforin 
51
. When it is exocytosed from the lytic granules at the IS, due to 
the extracellular neutral pH as well as high calcium (Ca
2+
) concentrations in the cleft, 
perforin loses its interaction with the proteoglycan and is released in its active form. 
High concentration of free Ca
2+
, a minimum of 200 μM 52 facilitates the activation 
and also polymerization of perforin to cylindrical polymers which are inserted into the 
target membrane to form pores 
46
 to permeabilize target cell membrane and facilitate 
entry of granzymes into target cells (Fig. 1) 
53
. Perforin is delivered directly to the 
target membrane by fusion of the lytic granule to the target membrane thus limiting 
the possiblity of it binding to the T cell membrane 
46
. 
 
1.3.3.2. Granzymes, lytic granule serine proteases 
Granular enzymes also called as granzymes are highly conserved serine proteases 
present in the lytic granules of CTLs and NK cells 
46
. They have also been reported to 
be present without perforin in non lymphoid cells like macrophages, dendritic cells, 
mast cells, basophils, keratinocytes, sertoli cells, photoreceptors and brain cells where 
their function is unknown 
54
. Five human granzymes (A, B, H, K, M) and ten mouse 
granzymes (A, B, C, D, E, F, G, K, M and N) have been reported till date 
53,54
. All the 
granzymes are monomeric polypeptide chains of 27 to 55 kDa molecular weights 
except granzyme A which is a disulphide bonded homodimer of 60 kDa 
55
. Of these, 
grazyme A and B are the most abundantly occurring ones. They are delivered into the 
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target cells by the pore forming perforin. On entering the target cells they induce 
apoptosis of the target cell by various mechanisms. They are also said to exhibit non-
cytotoxic functions like stimulation of pro-inflammatory cytokines, altering and 
remodeling the extracellular matrices, cleavage of viral peptides 
54
. 
As any other protein, the synthesis of granzyme protein is followed by its post 
translational modifications. Before it reaches the lytic granule, in the ER, its signal 
peptide is cleaved to form an inactive proenzyme which has an N- terminal dipeptide 
which needs to be cleaved to convert it to an active protease. In the Golgi apparatus 
mannose 6-phosphate residue tag, a sorting signal, is added to the proenzyme which 
targets them to the mannose 6-phosphate receptors containing lytic granules 
53
. Once 
it reaches the lytic granule, the N- terminal dipeptide is removed but even then 
remains as an inactive protease as it is bound along with perforin to proteoglycans and 
is inactive in the acidic pH of the granule and thus can be stored efficiently in the lytic 
granule 
56
. 
Perforin is the major carrier to deliver granzymes into the target cells. The most 
popular model is that granzyme enter target cells through pores generated by perforin. 
There is also evidence emerging to support the model that endocytosis following pore 
formation by perforin brings membrane-bound granzymes into the target cells (Fig. 1) 
57
. Granzymes use three major mechanisms to induced target cell apoptosis: (1) 
cleaving different cytosolic (Bid (BH3 interacting domain death agonist) protein) and 
nuclear (Histones, lamins, PARP1) substrates; (2) by mitochondrial and DNA 
damage; (3) inducing the caspase pathway by activating caspase 3 and also activating 
other caspases like caspase 7 and 8 which lead to cleavage and inactivation of 
Inhibitor of Caspase Activated DNase (ICAD) causing apoptosis 
53,54,58
. 
 
1. Introduction 
 
11 
 
1.3.4. Fas and Fas ligand pathway 
Another important mechanism by which the CTLs and NK cells eliminate their targets 
is by a receptor ligand pathway called the Fas/Fas ligand pathway. The occurrence of 
a cytotoxic pathway other than the perforin/granzyme pathway was observed in 
perforin knock out mouse CTLs and also in perforin deficient CTL cell line 
59
. This 
alternate pathway was confirmed to be the Fas/Fas ligand pathway, as they observed 
some killing activity in perforin deficient lymphocytes against Fas expressing target 
cells but this was eliminated when the same perforin deficient lymphocytes were used 
to kill Fas receptor deficient lpr-mutant cells which have defective Fas genes 
18,19
. 
Thus proving the existance of an alternate cytotoxic pathway induced by Fas/Fas 
ligand. At the IS, the Fas ligand expressed by the CTLs or the effector cells binds to 
the Fas receptor on the target cell, triggering the activation of apoptotic pathway 
leading to target cell death. 
Fas ligand (FasL) also called as CD95L, Apo-1L, CD178, TNFSF6 or APT1LG1, is a 
231 amino acid type 2 transmembrane protein belonging to the Tumor Necrosis 
Factor (TNF) family of death receptors 
60
. FasL has a TNF homology domain at its 
distal end, right next to which is the C-terminal receptor binding site that binds to the 
Fas receptors on the target cells 
61
. It has been shown that FASL is localized in the 
membrane of secretory lysosomes also called as lytic granules, which also contain 
perforin and granzymes 
62
. Upon formation of an IS with a target cell, the CTL 
releases lytic granules whose lipid bilayer fuses with the target cell plasma membrane 
exposing the FasL to interact with the Fas receptor 
63
. 
On engagement of FasL to the target cell Fas receptor, Death Inducing Signalling 
Complex (DISC) is activated leading to further activation of caspase 8 which directly 
mediates activation of downstream effector caspases -3, -6 and -7. Caspase 8 cleaves 
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BID to tBID which releases cytochrome C from mitochondria. Cytochrome C leads to 
the formation of Apoptosome where caspase 9 is activated which cleaves and 
activates downstream effector caspases causing apoptosis and target cell death 
64
. 
 
 
Figure 1: Target cell killing by CTL at the immunological synapse (IS) 
On TCR identification and binding of antigen-MHC complex of the antigen presenting cells or target 
cells, activation of CTLs leads to the killing of target cells at the IS by two main pathways. One is by 
release of perforin and granzymes from the lytic granules and the other is by the release of the FAS 
ligand. (Figure modified from Trapani, J.A. & Smyth, M.J., 2002). 
 
1.4. Sorting, delivery and maturation of proteins and vesicles through endosomal 
pathway 
As we already know, after the synthesis of cytotoxic molecules, they are targeted and 
transported (by mannose 6-phosphate receptor pathway) to the secretory lysomomes 
(lytic granules) and stored there. These secretory lysosomes also go through a 
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synthesis and maturation pathway before they are transported to the IS for their 
targeted secretion. The lytic granule and other lysosomal enzymes and proteins are 
synthesised in the ER and translocated to the cis-Golgi and then to the trans-Golgi of 
trans-Golgi Network (TGN). The trans-Golgi is the final port through which the cargo 
proteins are delivered to vesicles or to the cell surface 
65
. From the trans-Golgi, they 
can follow two different pathways to reach the lysosomes 
66
. One is the well studied 
indirect endocytic pathway, where proteins like lysosomal acid phosphatases are 
transported to the cell surface 
67
 in Adaptar Protein 1 (AP1) containing clathrin coated 
vesicles 
68,69
. From here it passes through different compartments of the endocytic 
pathway strating from early endosomes to late endosomes and then finally to the 
lysosomes for degradation or recycling back to the cell membrane or to return to the 
TGN (Fig. 2) 
70
. There is also a much faster direct pathway determined by the shorter 
transit time (half-time 1 to 2 hr) for transfer to the lysosomal compartment 
71
 
compared to the longer transit time (half-time approximately 6 hr) required for the 
indirect pathway 
67
. Lysosomal Associated Membrane Protein (LAMP) 1 is said to be 
delivered to the lysosome by this direct pathway 
71
 although in some cell types 
minority of the LAMP1 molecules have been shown to be delivered through the 
indirect / long pathway 
72
. Other proteins like FasL, Cytotoxic T-Lymphocyte antigen 
4 (CTLA4), proteins with mannose 6-phosphate tags also follow the direct route to 
lysosomes but some proteins like CD63 (LAMP3) can be delivered by both direct and 
indirect pathways 
73,74
. The route taken by the cargo transported through the direct 
pathway can be described as follows: the cargo is dispatched from the TGN by 
budding into vesicles or fusion into early endosomal compartments which then fuses 
with or transforms to late endosomes from which it finally becomes or fuses with 
lysosomes. Many molecules are essential for the formation or fusion of early 
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endosomal compartment. Rab 5, a regulatory gaunosine triphosphatase which belongs 
to the family of small Guanosine TriPhosphatases (GTPase) is a marker for early 
endosomes and is considered to regulate sorting endosome fusion. Rab 5 has two 
effectors, Rabaptin-5 and Early Endosome Autoantigen 1 (EEA1) which is an another 
marker of early endosomes 
75,76
. Rab 5 binds to EEA1 which forms a high molecular 
weight complex with Rabaptin-5 in the presence of N-ethylmaleimide Sensitive 
Factor (NSF). This complex then interacts with certain SNARE proteins driving the 
membrane fusion of the vesicles 
77
 delivering the cargo. Cargo transport from early 
endosomes to late endosomes can be either through evolution of the early endosomes 
into late endosomes by the loss of their receptors / markers to gain new receptors or 
by simple transfer of cargo from the early endosome vesicles to late endosome 
vesicles. This was answered by the observation of loss of Rab5 marker and gain of 
Rab7 (a late endosome marker, also a member of the family of GTPase) in the cargo 
carrying vesicles. Thus confirming that coordinated exchange of Rab5 to Rab7 is the 
mechanism of cargo progression between early and late endosomes 
78
. The final 
transfer of the cargo from late endosomes to lysosomes can take place in three 
different ways. Firstly by vesicular transport between two organelles which has not 
yet been proven. Secondly by ‘kiss and run’ mechanism, where transient fusion pores 
are formed when the late endosome comes in contact with the lysosomal vesicle and 
the cargo is transferred through by repeated transient fusion and fission 
79
. The final 
hypothesis is by direct and complete fusion of late endosomes with lysosomes leading 
to the formation of a hybrid organelle with subsequent regeneration of lysosomes 
80
. 
This was supported by the possibility to collect late endosome-lysosome hybrid 
organelles which have characteristics of both late endosomes and lysosomes 
81
. It has 
been shown that the fusion between late endosomes and lysosomes is ATP, cytosol 
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and temperature dependent and requires the presence of NSF, Soluble NSF 
Attachment Protein (SNAP), SNARE proteins and Rab-GTPase 
82,83
. 
 
1.5. SNARE proteins 
Membrane fusion which is crucial for the trafficking and secretion of the vesicle 
cargo is facilitated by the participation of conserved membrane-associated proteins 
called the Soluble N-ethylmaleimide sensitive factor Attachment protein (SNAP) 
Receptors (SNAREs). They are found throughout the secretory pathway, participating 
in membrane-trafficking, docking, priming and fusion of vesicles (loaded with cargo 
like secretory enzymes, neurotransmitters etc) (Fig. 2). 36 human SNAREs have been 
identified. SNAREs belonging to the different families have specific localization and 
function and their dynamic cycle of assembly and disassembly is regulated by NSF, 
SNAP and Rab-GTPases 
84,85
. SNAREs were originally classified functionally as v-
SNAREs or vesicular membrane SNAREs (Synaptobrevin / Vesicle Associated 
Membrane Protein 2 (VAMP2)) and t-SNAREs or target membrane SNAREs 
(Syntaxin 1, SNAP-25) on the assumption that each SNARE is localized either on the 
donor or the acceptor membranes 
86
. As this classification is not applicable for 
homotypic fusion (fusion of structurally and functionally similar vesicles), SNAREs 
are then classified structurally as R- and Q-SNAREs depending on whether they 
contain the highly conserved Arginine (R) or Glutamine (Q) residues in the SNARE 
motif 
87
. The core of the SNARE complex is composed of four intertwined coiled coil 
parallel α-helices with each helix provided by one SNARE motif. The centre of this 
bundle consists of 16 stacked layers of interacting side chains and most of these layers 
are hydrophobic except for the central ‘0’ layer which consists of highly conserved 
three Q residues and one R residue 
87
. Accordingly, these are subdivided into Qa-, 
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Qb-, Qc- and R- SNAREs 
88
. Each of these has different N-terminal domains, one 
respective Qa-, Qb-, Qc- or R- SNARE motif and mostly a C-terminal transmembrane 
domain. In addition there is also a subclass of SNAREs, which have one Qb- and one 
Qc- SNARE motif, hence they are called the Qbc- SNAREs, such as SNAP-23, 
SNAP-25, SNAP29 and SNAP-47. It is necessary that at least one SNARE (having a 
transmembrane domain) that is participating in the formation of the SNARE complex 
should be contributed by each of the fusing membrane during the assembly of a trans-
SNARE complex 
89
. These SNARE motifs assemble and intertwine starting from the 
N-terminal domain and zippering inwards towards the C-terminal membrane anchor 
domain which causes the fusion of the participating membranes 
90-92
. The following 
table 1 shows the classification of members into various SNARE families 93: 
Table 1: Classification of SNAREs 
 
Qa-SNARE Syntaxin 1 (Stx1), Stx2, Stx3,  Stx4, Stx5, Stx7, Stx11, 
Stx13, Stx16, Stx17, Stx18 
Qb-SNARE Vti1a, Vti1b, GS27, GS28 
Qc-SNARE Stx6, Stx8, Stx10, GS15, BET1, SLT1 
Qbc-SNARE SNAP-23, SNAP-25, SNAP29, SNAP-47 
R-SNARE VAMP-1, VAMP-2, VAMP-3, VAMP-4, VAMP-
5,VAMP-7,  VAMP-8, SEC22b, YKT6 
unclassified D12,SEC20,SEC22a and SEC22c 
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Figure 2: SNAREs involved in the endosomal trafficking pathway of a representative animal cell 
Different SNAREs are expressed and participate in the trafficking of proteins through the endosomal 
pathway. The proteins synthesized in the ER are transported through the trans-Golgi network to the 
early, late and lysosomal compartments for release or are recycled back by the recycling endosomes. 
(Figure modified from Kanehisha Laboratories, 2010). 
 
1.6. SNARE and related proteins in immune cells 
SNAREs have been extensively studied for their role in neurotransmitter release in 
neurons. Studies in immune cells showed the presence and formation of SNARE 
complexes for membrane fusion and exocytosis of secretory vesicles, but the 
interacting SNARE partners differed from those seen in neuronal cells. Mast cells, 
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eosinophils, basophils, macrophages, NK cells, CD4
+
 cells and CTLs are some of the 
immune cells where SNAREs were detected to be present. VAMP7 and not VAMP2 
was found to be crucial for NK cell mediated target killing and also for exocytosis in 
neutrophils and eosinophils 
94,95
. It has been shown in NK cells that SNAREs are 
essential for the polarized exocytosis of intracellular recycling vesicles (like TCR 
vesicles) at the IS. t-SNAREs like Syntaxin 4 and SNAP-23 and v-SNARE VAMP-3 
(and maybe VAMP-2) forming the SNARE complex that mediates vesicle fusion are 
involved in the TCR targeting to the IS 
96
. Munc family proteins bind to the amino 
terminal domains of Syntaxins and regulate the availability of Qa-SNAREs during the 
formation of the trans-SNARE complex. The qRT-PCR conducted with naïve and 
anti-CD3 / anti-CD28 coated bead stimulated CD8
+
 T lymphocytes showed that some 
SNAREs like Syntaxin 1A (Stx1A), Stx1B, Stx19, Vti1a, SNAP-25 are not expressed 
in human CTLs. While SNAREs like Stx2, Stx5, Stx11, Stx17, Stx18, SNAP-23, 
SNAP-25 and VAMP1, 2, 5, 7 and 8  are expressed in human CTLs. Other SNAREs 
expressed in human CTLs are Stx3, Stx4, Stx6, Stx7, Stx8, Stx13, Vti1b, VAMP3 and 
VAMP4 that colocalized with CD3 and Vti1b, Stx8 and Stx16 that showed highest 
degrees of colocalization with lytic granules. Out of the 4 members of the Munc13 
family (Munc13-1, Munc13-2, Munc13-3 and Munc13-4) only Munc13-4 expression 
was detected in human CTLs 
1
. Deficient of several SNARE or related proteins 
(Stx11, Munc13-4, Munc18-2, Rab27a) in key steps of vesicle trafficking, priming 
and release leads to life-threatening immune disorders 
48,97
. Qa-SNARE, Syntaxin 7 
has been demonstrated to be important for TCR trafficking 
98
 and a Qb-SNARE, 
Vti1b is required for the tethering of lytic granules with TCR endosomes which leads 
to the efficient docking and release of the lytic granules at the IS in CTLs 
45
. The 
importance of SNARE and Munc proteins in CTL functioning has been proven by the 
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genetic diseases caused by mutations in the genes coding these proteins. Some of the 
diseases caused by mutations in SNARE and SNARE related proteins are mentioned 
as follows: Griscelli syndrome type 2 (GS-2) is an autosomal recessive disorder which 
is also called as Chédiak-Higashi like syndrome, where altered Rab27a GTPase 
causes defective pigmentation and impairment in lytic granule docking at the IS in 
NK cells and CTLs 
97
. HLH is a severe hyper inflammatory syndrome caused by 
uncontrolled but ineffective immune response. Primary HLH, also known as Familial 
Hemophagocytic LymphoHistiocytosis (FHL) is a heterogenous autosomal recessive 
disorder affecting the granule dependent exocytosis pathway 
99
. Five different FHLs 
have been identified based on the mutations at five different loci. Mutation in 
chromosome 9q21.3-22 leads to FHL1 
100
. Defect in the PRF1, perforin gene causes 
reduction in perforin synthesis impairing the perforin / lytic granule dependent 
cytotoxicity of NK cells and CTLs 
101
. FHL3 is a result of mutations in UNC13D gene 
that codes for Munc13-4 protein required for the priming step of lytic granule 
secretion preceding vesicle membrane fusion at the IS 
102
. FHL4 is caused by defect 
in the encoding and expression of Syntaxin 11 protein in NK cells and CTLs resulting 
in partial impairment in granule exocytosis without hindering granule polarization. A 
partial repair of this defect is possible by IL-2 restimulation 
103
. Mutation in STXBP2 
gene encoding Munc18-2 causes FHL5 were in defective exocytosis of the lytic 
granules in NK and CTLs is observed. Munc18-2 is known to bind with Syntaxin 11 
to bring about the release of lytic granules 
104
. All these establish the fact that SNARE 
and SNARE related proteins are indeed very significant for NK and CTL cytotoxicity. 
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1.7. Syntaxin 8: the protein of interest 
Syntaxin 8 is a Qc- SNARE of 236 amino acid length with 27 kDa molecular weight. 
PC12, Cos7 and HeLa cell lines, Chinese Hamster Ovary (CHO) cells, Normal Rat 
Liver (NRL), Normal Rat Kidney epithelial cells (NRK) 
105,106
, murine lymphocytes 
are some of the cell types in which Syntaxin 8 has been studied but its function has 
not yet been studied in human CTLs. Syntaxin 8 protein is encoded by a STX8 gene 
that maps to chromosomal band17p12. N-terminal region of the Syntaxin 8 protein 
contains a coiled coil domain, which is followed by another coiled coil domain that is 
highly conserved and is called the coiled coil domain 2 or t-SNARE domain. The t-
SNARE domain is followed by a hydrophobic trans-membrane anchor at the C-
terminal region 
107
. Two major groups of sorting signals that efficiently sort different 
membrane proteins to various post Golgi compartments have been identified to be 
tyrosine based motifs and di-leucine / dihydrophobic motifs. The tyrosine-based motif 
carriers out the indirect route, that is, transport to the plasma membrane and then to 
the endosomes whereas the di-leucine motif mediates the direct transport to late 
endosomes 
108
. But the presence of two distinct di-leucine motifs on a protein can 
independently mediate transport by both direct and indirect pathways. Syntaxin 8 has 
been shown to comprise this functionally distinct two di-leucine motifs at amino acids 
77-83 and 184-190 and that these independently function for exocytosis and 
endocytosis respectively. Thus indicating that Syntaxin 8 is internalized from the 
plasma membrane by the indirect pathway and also directly delivered from the TGN 
to endosomal / lysosomal population. This can also be explained by the hypothesis 
that Syntaxin 8 may be delivered from the TGN directly to endosomal / lysosomal 
populations, rather than being transported to the plasma membrane but then recycled 
to endosomes by the plasma membrane endosome route 
109
. This is supported by the 
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studies showing the localization of Syntaxin 8 (in murine cells and cell lines) in early 
endosomal 
105
, late endosomal compartments 
110
 and also in TGN. It has also been 
shown that in CHO cells, Syntaxin 8 mainly colocalizes in non-clathrin coated 
vesicles, thus ruling out its involvement in clathrin mediated endosomal pathway 
106
. 
It has been predicted that Syntaxin 8 is one of the interacting partners of the SNARE 
complex formed by VAMP7, Syntaxin7 and Vti1b 
111-113
. In Cos7 cells Syntaxin 8 has 
been shown to be localized in the recycling endosomes 
114
. Some studies have shown 
that Syntaxin 8 is one of the SNAREs expressed in human CTLs and that it may play 
a role in CTL function. It has been shown to colocalize with lytic granules in CTLs 
1
. 
It has also been shown to co-immunoprecipitate with a Qa-SNARE, Syntaxin 7, that 
is required for the TCR trafficking to the IS in human CTLs 
98
. But the functions of 
Syntaxin 8 in human CTLs still remain to be identified. 
 
1.8. Aims of this study 
SNARE and SNARE related proteins have already been shown to participate in the 
vesicle trafficking pathway in various cell types. The screening of expression of 
different SNAREs in primary human CTLs proved the expression of many SNAREs 
in human CTLs. Among them, Syntaxin 8 was highly expressed in naïve and 
activated CD8
+
 T cells. Furthermore, some SNAREs like Vti1b, Stx8 and Stx16 
showed highest degrees of colocalization with lytic granules in CTLs 
1
. One of the 
mechanism by which the CTLs kill their targets is by lytic granule release at the IS. 
SNAREs and SNARE related proteins are believed to be involved in the trafficking of 
cytotoxic molecules to the IS in CTLs. Up to date, Qa-, Qb-, R-SNARE haven been 
reported to be involved in CTL function, however, no Qc-SNARE protein has been 
revealed to regulate CTL function. Therefore in this work the main focus is on 
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Syntaxin 8, a Qc-SNARE, which partially colocalizes with lytic granules and 
accumulates at the IS, indicating a potential promising role in CTL function. Thus we 
aim to study the significance of Syntaxin 8 in human CTL cytotoxicity. In this study, 
we try to answer several problems, of which first of all we try to determine the 
localization of Syntaxin 8 in human CTLs. Then we determine its effect on the CTL 
cytotoxicity and also try to identify the mechanisms it may be involved in, that might 
influence CTL function. To answer these, we use different techniques like immuno-
cytochemistry, imaging, various molecular biological, biochemical and functional 
assays. 
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2. MATERIALS AND METHODS 
 
2.1. Antibodies and Reagents  
Antibodies used  are Alexa
488
-labelled anti-CD3 mAb (UCHT1, Biolegend), Alexa
647
-
labelled anti-CD3 mAb (UCHT1, Biolegend), Alexa
647
-labelled anti-Perforin mAb 
(dG9, Biolegend), Alexa
488
-labelled anti-LAMP1 mAb (H4A3, Biolegend), mouse 
anti-EEA1 mAb (BD Biosciences), Alexa
568
-, Alexa
647
- andAlexa
488
- labelled goat 
anti-rabbit secondary Ab and Alexa
568
- and Alexa
488
- labelled goat anti-mouse 
secondary Ab (Life Technologies), rabbit polyclonal anti-Syntaxin8 Ab (Synaptic 
Systems), rabbit anti-γ-tubulin Ab (Sigma), rabbit polyclonal anti-Perforin Ab (H-
315, Santa Cruz), rabbit polyclonal anti-Granzyme B Ab (Cell Signaling), rabbit 
polyclonal anti-CD178 Ab (FASL-Q20, Santa Cruz), horseradish peroxidase anti-
rabbit secondary antibody (Amersham), mouse anti-CD28 Ab (BD Biosciences), 
mouse anti-CD3 Ab (AbD seroTec), FITC labelled anti-human Perforin (dG9 clone, 
BioLegend), FITC Mouse IgG2b (MPC-11) κ isotype Control, rabbit polyclonal anti-
mouse Immunoglobulins (DakoCytomation).  
All reagents used, if not specifically mentioned, are from Sigma (highest grade). 
 
2.2. Peripheral blood mononuclear cell (PBMC) isolation 
Human blood from healthy donors collected in leukoreduction system chambers 
(LRSCs) by the Department of Clinical Hemostaseology & Transfusionmedicine, 
Homburg, was used to isolate PBMCs. LRSCs are used to eliminate the 
contaminating leukocytes from blood products at the point of blood collection to 
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prevent allo-immunization and associated risks during transfusion 
115-117
. These 
LRSCs are a source of viable human PBMCs. 
Leucosep
TM
 filtered tube (227290, Greiner) containing 15-17 ml lymphocyte 
separation media-1077 (LSM) (PAA, J15-004) was prepared for the PBMC isolation 
by centrifuging at 1000 g, 30 sec at room temperature (RT). Then the blood in the 
LRSC was flushed with 20-25 ml HBSS (Hank’s BSS, PAA labs, 15–009) into the 
prepared Leucosep
TM
 tube. The leukocytes, plasma and erythrocytes were separated 
by density gradient centrifugation at 450 g (Hettich - Centrifuge 32R) for 30 min at 
RT (Break = 0, Acceleration = 1). The leukocyte white ring, found just below the 
plasma layer, was transferred into a falcon tube and the volume was made up to 50 ml 
with HBSS and centrifuged at 250 g for 15 min at RT (Break = 9, Acceleration = 9, 
Hettich-Centrifuge 32R). Supernatant was discarded and if necessary the erythrocytes 
in the red ringed pellet were lysed, depending upon the size of the pellet, using 1 to 3 
ml of lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.3) to 
resuspend the pellet for 60-120 sec. 50 ml HBSS was added to stop the lysis and then 
centrifuged at 130 g for 10 min at RT (Break = 9, Acceleration = 9, Hettich-
Centrifuge 32R) after which the supernatant was discarded to obtain an erythrocyte 
free PBL pellet that was resuspended in 20 ml PBS (Phosphate Buffer Saline)/0.5 % 
BSA solution and stored at 4
o
 C or stimulated with Staphylococcal enterotoxin A 
super antigen. 
 
2.3. Stimulation of PBLs with Staphylococcal enterotoxin A 
Staphylococcal Enterotoxin A (SEA) is a bacterial (Staphylococcal aureus) toxin 
which is secreted to impair host humoral responses and immune recognition. In 
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organisms it rapidly elevates many cytokines like interleukin-2 (IL-2), interferon-γ 
(IFN- γ), and tumor necrosis factor α (TNF-α) to toxic levels 118.  
It belongs to a family of superantigens (SAg) as it is a strong mitogen which activates 
a large fraction of T cells. It can interact with major histocompatibility complex 
(MHC) II molecules leading to the activation of CD4
+
 and CD8
+
 T lymphocytes 
118-
122
, subsequently causing SAg induced T cell mediated B cell depletion leading to 
SAg-dependent cell-mediated cytotoxicity (SDCC) 
122,123
. 
PBMCs isolated from healthy donors were stimulated with SEA (0.05 μg/ml) at a 
density of 1.5 × 10
8
 cells/ml, for 1 hr at 37°C. These PBMC were resuspended at a 
density of 4 × 10
6
 cells/ml in AIMV medium (Life Technologies, Cat. No: 12055) 
supplemented with 10 % FCS (Life Technologies, Cat. No: 10270-106) and 100 U/ml 
of recombinant human IL-2 (Life Technologies, Cat. No: PHC0021). After 5 days, 
SEA-specific CTL were positively isolated. 
 
2.4. Positive isolation of CD8
+
 T lymphocytes 
Synthetic magnetic beads that are coated with anti- CD8 antibody are used to fish the 
CD8
+
 CTLs out of the PBMC mixture. 5 days after the SEA stimulation, PBLs were 
positively isolated with magnetic Dynabeads (Life Technologies). 1x10
7
/ml of SEA 
stimulated PBLs were centrifuged at 220 g (Hettich-Centrifuge 32R) for 8 min at 4°C. 
Pellet was then resuspended in 1 ml ice cold buffer 1 (PBS/0.5 % BSA). Anti-CD8 
antibody coated magnetic dynabeads bind specifically to CD8
+
 T cells, thus 
selectively separating them from the PBL mixture. 25 µl of dynabeads were washed 3 
times with 1 ml buffer 1 for 1 min each before use. These washed beads were then 
added to the ice cold cell suspension and incubated at 4°C for 20 min on a rotator. The 
CD8
+
 T cells now bound to the dynabeads were separated from the rest of the solution 
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using a magnetic separator for 2 min. These bead bound cells were washed 3 times 
with 1 ml ice cold buffer 1 for 1 min each using a magnetic separator. This step 
allows the removing of cells that are nonspecifically bound to the beads. 
The bead bound cells were then resuspended with 100 µl of buffer 2 (RPMI 1640/ 1 
% FCS) and 10 µl of DETACHaBEAD (Life Technologies) and incubated at room 
temperature for 45 min on a rotator. The DETACHaBEAD detaches the CD8
+
 T cells 
from the dynabeads. These detached CD8
+
 T cells were separated from the beads 
using a magnetic separator for 1 min. The supernatant containing the CD8
+
 T cells 
was collected in a separate tube. The beads were washed 3 times for 1 min each with 
50 µl buffer 2, to collect any remaining CD8
+
 cells that were still binding to the beads. 
The collected cell supernatant was resuspended and the volume was made up to 1 ml 
using buffer 2 and centrifuged at 400 g (Hettich-Centrifuge 32R) for 6 min at room 
temperature, to remove the DETACHaBEAD. Pellet obtained was resuspended in 
AIMV/10 % FCS with 100 units/ml IL-2 (Stock 1000 units/µl). The CD8
+
 T cells 
were then plated at a density of 1.5x10
6
 cells/ml and cultured until further use. 
 
2.5. Negative isolation of CD8
+
 T lymphocytes 
CD8 negative isolation kit (Life Technologies) is used to isolate naïve CD8
+
 T cells 
from PBMCs. 1x10
7
 PBMCs were centrifuged at 220 g (Hettich-Centrifuge 32R) for 
8 min at 4°C and the pellet obtained was resuspended in 100 µl cold PBS/0.5 % BSA 
(buffer 1). 20 µl FCS and 20 µl antibody mix (provided in the kit) were added to the 
cells and incubated at 4°C for 20 min on a rotator. Magnetic depletion beads provided 
in the kit are used to bind and remove all PBMCs other than CD8
+
 T cells, thus 
isolating untouched CD8
+
 T cells. 200 µl of depletion beads were washed 3 times 
with at least 1 ml of ice cold buffer 1 for 1 min each before use. After the 20 min 
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incubation, the cells were resuspended well in 2 ml cold buffer 1 and centrifuged at 
300 g (Hettich-Centrifuge 32R) for 8 min at 4°C. Pellet obtained was resuspended in 
800 µl cold buffer, mixed with pre washed 200 µl depletion beads and incubated for 
15 min at RT on a rotator. These cells were gently resuspended for 5 times before 
adding 1 ml of cold buffer 1. The unwanted PBMCs bound to depletion beads were 
separated by placing in a magnet for 2 min. The supernatant containing untouched 
CD8
+
 T cells was collected in a new tube. The beads were washed twice with buffer 
1, placed in the magnet and supernatant collected as said earlier. The supernatant 
containing the untouched CD8
+
 T cells, was centrifuged at 200 g (Hettich-Centrifuge 
32R) for 5 min at RT. The pellet was resuspended in AIMV/10 % FCS and the cells 
were plated at a density of 3x10
6
 cells/ml until further use. 
 
2.6. siRNA transfection of CTLs 
To knockdown the expression of Syntaxin 8, we used RNA interference by 
small/short interfering RNA (siRNA). siRNA are small double stranded RNA 
molecules of 20-25 nucleotides in length. They interfere with the transcription of 
specific mRNA by binding of complimentary nucleotide sequence thus inhibiting the 
protein expression 
124
. Modified control and Syntaxin 8 siRNA (Qiagen) were used 
for transfection. 2’-OMe modification stabilizes the siRNA by making it more 
resistant to nucleases thus increasing the siRNA interference efficacy 
125
. Control 
siRNA (Qiagen) used here is a scrambled siRNA with no homology to any known 
mammalian genes. 
These siRNA were transfected into primary human CTLs through nucleofection 
126,127
 
by Amaxa technology (Lonza). Lyophilized modified siRNA is reconstituted by 
dilution in resuspension buffer or dH2O provided by the company (Qiagen). 100 µl 
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resuspension buffer or water was added to prepare a dilution of 200 μM solution. 
From this 30 µl was taken and added to 270 µl resuspension buffer to get 300 µl of 20 
μM solution (1:10 dilution). 
6x10
6
 CTLs were centrifuged at 100 g (Hettich-Centrifuge 32R) for 8 min at RT and 
pellet was resuspended in 100 µl of nucleofector-supplement solution (Lonza Human 
T cell nucleofactor kit (Cat. No: VPA-1002) and P3 Primary Cell 4D-Nucleofector™ 
X Kit (Cat. No: V4XP-3024)). 10 µl of 20 µM modified Syntaxin 8 siRNA was added 
to this, resuspended well and electroporated in special Amaxa (Lonza) vials with the 
programme optimal (T-023 in the Lonza nucleofactor II and E0-115 programme in the 
Lonza 4D Nucleofactor) for primary human CD8
+
 T lymphocytes. Immediately after 
the electroporation, 500 µl warm AIMV media with 10 % FCS was added to the 
transfected cells, which were then transferred to 12 well cell culture plate (BD falcon) 
making the volume of the media upto 1.5 ml per well. 12 hr after transfection, the 
cells were centrifuged at 100 g (Hettich-Centrifuge 32R) for 8 min at RT. Fresh 
AIMV/10 % FCS media with 50 U/ml IL-2 (Stock 1000 units/µl) was added to the 
cells which were then plated at 1.5 x10
6
 cells/ml and incubated in 37
o
C till further use 
(36 hr after transfection). 
The siRNAs used are from Qiagen unless mentioned otherwise. The target sequences 
of the different siRNAs used are as follows: 
unmodified Syntaxin 8 siRNA, Hs-Stx8_5 (Cat. No: SI03071929): CAG GTC CAG 
CCT GAT GAG TGA and modified Syntaxun 8 siRNA, Hs_Stx8_5 (SI03071929, 
Cat. No: 1021962): 5’ r(OMeC-OMeA-GGU CCA GCC UGA UGA) d(GUG) 
d(OMeA-OMeT-OMeT) 3’; 5’ (dU r(CA CUC AUC AGG CUG GAC) d(OMeC-
OMeU-OMeG) 3’.  
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Unmodified negative control siRNA (Cat. No: 1027310): 5’ UUC UCC GAA CGU 
GUC ACG UdT dT 3’; 5’ ACG UGA CAC GUU CGG AGA AdT dT 3’) and 
modified control siRNA (Cat. No: 1021962): 5’ r(OMeA-OMeA-UUC UCC GAA 
CGU GUC) d(ACG) d(OMeU-r(OMeT-OMeT)) 3’; 5’ A r(CG UGA CAC GUU 
CGG AGA) rA d(OMeU-OMeU-r(OMeT-OMeT)) 3’. Modified Vti1b siRNA (Cat. 
No: 4479): 5’r (OMeA-OMeA-GGA CCU UGC UAA ACU) d(CCA) d(OMeU-
OMeT-OMeT) 3’; 5’ d(U) r(GG AGU UUA GCA AGG UCC-OMeT-OMeT)3’ and 
unmodified Syntaxin 6 siRNA (Dharmacon, Cat. No: L-017164-00-0005, clone 
NM_005819) which is a pool of 4 different unmodified siRNAs as follows:  
J-017164-05,Stx6: G.C.A.G.U.U.A.U.G.U.U.G.G.A.A.G.A.U.U.U.U;  
5’-P.A.A.U.C.U.U.C.C.A.A.C.A.U.A.A.C.U.G.C.U.U 
J-017164-06, Stx6: C.A.G.C.A.U.A.G.U.U.G.A.A.G.C.A.A.A.U.U.U;  
5’-P.A.U.U.U.G.C.U.U.C.A.A.C.U.A.U.G.C.U.G.U.U 
J-017164-07,Stx6: G.C.C.C.A.G.G.G.A.U.U.G.U.U.U.C.A.G.A.U.U;  
5’-P.U.C.U.G.A.A.A.C.A.A.U.C.C.C.U.G.G.G.C.U.U and 
J-017164-08,Stx6: U.A.U.C.U.C.A.U.A.U.G.A.C.C.A.G.U.G.A.U.U;  
5’-P.U.C.A.C.U.G.G.U.C.A.U.A.U.G.A.G.A.U.A.U.U 
Perforin-mCherry, Rab7-mCherry and Rab11-mCherry were the constructs used in 
this study. Perforin was amplified from human cDNA with primers 5’ TAT ATA 
AGA TCT CCA CCA TGG CAG CCC GTC TGC TCC and 5’ TAT ATA TAC CGG 
TGG CCA CAC GGC CCC ACT CCG G with BglII and Age1 restriction sites. After 
AgeI and BglII restriction digestion, perforin was ligated to mCherry vector to yield a 
C-terminal tagged perforin-mCherry.  
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Rab 7 and Rab 11 were also amplified from human cDNA with Eco R-1 and Bam H-1 
restriction sites. The primers used for these are as follows: Rab 7: 5’ TAT ATG AAT 
TCT ATG ACC TCT AGG AAG AAA GTG T and 5’ TAT ATA GGA TCC TCA 
GCA ACT GCA GCT TTC TG. After Eco R-1 and Bam H-1 restriction digestion, 
Rab 7 was ligated to mCherry vector to yield an N-terminal tagged Rab 7-mCherry.  
Rab 11: 5’ TAT ATG AAT TCT ATG GGC ACC CGC GAC GAC and 5’ TAT ATA 
GGA TCC TTA GAT GTT CTG ACA GCA CTG. After Eco R-1 and Bam H-1 
restriction digestion, Rab 11 was ligated to mCherry vector to yield an N-terminal 
tagged Rab 11-mCherry. 
The mCherry construct was a kind gift from Roger Tsien (Howard Hughes Medical 
Institute, University of California, San Diego, La Jolla, CA) 
1,45
. 
 
2.7. RNA isolation, reverse transcription and Quantitative Real Time-
Polymerase Chain reaction (qRT-PCR) 
Total RNA was isolated from cells treated with TRIzol® reagent (Life Technologies, 
Cat. No: 15596018) including 1 µl Glycogen (5 µg/µl, Life Technologies, Cat. No: 
10814-010) according to the following protocol: 
Cells (1-1.5 × 10
6
 cells for each sample) were harvested by centrifugation at 200 g for 
5 min and then the pellet was stored in 800 µl TRIzol and stored at -80°C until further 
use. To isolate the RNA from these cell samples, the pellet dissolved in TRIzol was 
centrifuged at 12000 g for 10 min at RT. The supernatant was transferred to a fresh 
eppendorf tube and incubate for 5 min at RT. 200 µl of chloroform per 800 µl TRIzol 
is added and shaken vigorously for about 15 sec and left at RT for 2-3 min. This is 
then centrifuged at 12000 g for 15 min at 4°C. The aqueous phase obtained is 
transferred to a fresh tube to which 1 µl Glycogen (5 µg/µl) is later added. To this 500 
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µl of Isopropanol is added and incubated for 10 min at RT and then centrifuged at 
12000 g for 10 min at 4°C. The supernatant is removed and pellet is resuspended in 1 
ml of 75 % ethanol (prepared with DEPC-treated H2O) and centrifuged at 7500 g for 
5 min at 4 °C. The RNA pellet is left to dry at RT and then the RNA is dissolved in 10 
µl of DEPC-treated H2O. The concentration of RNA is determined using 2 % agarose 
gel. 
0.8 µg total isolated RNA were then reverse transcribed into cDNA using 
SuperScript™ II reverse trancriptase (Life Technologies, Cat. No: 18064-014) with 1 
µl RNaseOut, (Life Technologies, Cat. No: 10777-019) and 1 µl oligo dT Primer (0.5 
µg/µl, Life Technologies, Cat. No: 18418-012) as per the manufacturer’s instruction. 
RealTime PCR was carried out in either MX3000 instrument from Stratagene or 
CFX96
TM
 Real-Time System C1000
TM
 Thermal Cycler (Software Biorad CFX 
Manager, Version 3.0). 1 µl of the cDNA prepared by reverse transcription was 
amplified using 300 nM of each primer were set into PCR reactions (25 µl) using 
Quanti Tect SYBR green kit (Qiagen, Cat. No: 204145). The conditions used in the 
thermal cycle of this PCR were: initial denaturation, 15 min, 94°C; 45 cycles: 
denaturation, 30 sec, 94°C; annealing, 45 sec, 58°C; elongation, 30 sec, 72°C 
followed finally with a dissociation curve cycle (60 sec, 95°C; 30 sec 55°C; 30 sec 
95°C; 30 sec 25°C). Primers were designed using Primer3 program-170 
128
 available 
at  http://frodo.wi.mit.edu/. PCR fragments obtained were confirmed by sequencing 
(MWG). In the qRT-PCR experiments, expression of Syntaxin8 was normalized to 
the average expression of two reference genes RNA Polymerase II and TATA box-
binding protein.  
The primer pairs used here are:  
Syntaxin 8: 1) (Gene bank accession number NM_005819): (forward primer)  
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5’ GGAGCATAGAGTGGGATCTA 3’, (reverse primer) 5’ TCATGTCCCTGACAA 
CTTGC 3’; 2) (NM_004853): (forward) 5’ ACCGAAGACAGAACCTCTTG 3’, 
(reverse) 5’ CGCTTAGCCTCTTCACTCAT 3’; TBP (NM_003194): (forward) 5’ C 
GGAGAGTTCTGGGATTGT 3’, (reverse) 5’ GGTTCGTGGCTCTCTTATC 3’; 
RNAPol II (NM_000937): (forward) 5’ GGAGATTGAGTCCAAGTTCA 3’, 
(reverse) 5’ GCAGACACACCAGCATAGT 3’; perforin1 (NM_005041 variant 1, 
NM_001083116 variant 2): (forward) 5’ ACTCACAGGCAGCCAACTTT 3’, 
(reverse) 5’ CTCTTGAAGTCAGGGTGCAG 3’ and Vti1b (NM_006370): (forward) 
5’ AGGTGAGAAGCACACCTTTG 3’ and (reverse) 5’ GCATTGCCCTTTGAGAC 
TGT 3’. 
 
2.8. Real Time killing assay 
Raji is a human Burkitt’s lymphoma cell line 129 which is used as target cells in this 
study. These Raji cells (ATCC, Cat. No: CCL-86™) were cultured in RPMI 1640 
medium (Life Technologies, Cat. No: 21875) supplemented with 10 % FCS.  
Killing of target SEA pulsed Raji cells, by SEA stimulated CTLs over a time period 
of 4 hr is measured by real time killing assay. Here the target cells were loaded with 
fluorescent Calcein AM ester which on entering the cells, is enzymatically converted 
to Calcein. On being killed by CTLs, the target cell membrane loses its integrity, 
releasing the dye 
130
. This reduction in fluorescence is measured over time of 4 hr for 
every 10 min.  
Target cells (Raji cells) were pulsed with SEA (10 µg/ml, 1 µl stock solution in 100 
µl of AIMV, up to 5x10
5
 cells/well in a 96-well plate BD Biosciences, Cat. No: 
353948 and 353219, black/transparent bottom) and incubated at 37°C for 30 min. 
Pulsed cells were resuspended and transferred to 1.5 ml EP-tube and the bottom of the 
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well is washed once with 100 µl of AIMV to take all the cells. Cells were centrifuged 
at 200 g (Hettich-Centrifuge 32R), 5 min, RT and supernatant discarded. AIMV+10 
% FCS (or AIMV media without FCS) with 10 mM HEPES (AIMV-HEPES) was 
prepared. During (or before) the centrifugation, 500 nM Calcein solution was 
prepared in AIMV-HEPES and vortexed rigorously. 1x10
6
 cells were resuspended in 
1 ml 500 nM Calcein solution (scale up or down according to the cell number 
needed). These Calcein-loaded cells were incubated in dark at room temperature for 
15 min with tilting. Then the cells were spun down (flash spin for about 7-8 sec) and 
washed once with the same volume of AIMV-HEPES and spun again as before. The 
cells were resuspended in the desired volume with AIMV-HEPES. 3x10
4
 cells in 200 
µl of AIMV-HEPES/well were plated in a 96 well plate and the cells were allowed to 
settle for at least 10 min. The killer cells (CTLs) were centrifuged at 200 g (Hettich-
Centrifuge 32R) for 5 min, RT and the pellet was resuspended in the desired volume 
of AIMV-HEPES to make different dilutions (killer to target cell ratios used are: 10:1 
and 20:1). 50 µl of CTL suspension was added to respective wells. The Calcein in the 
cells was excited at 485 nm and the emitted fluorescence was measured at 535 nm on 
a plate reader (GeniosPro, TECAN) which was pre warmed to 37°C. The instrument 
settings were as follows: bottom reading, no shaking, 37°C, optimal gain and 2 
flashes of exciting fluorescence for each of the single points out of the 9 points 
measured for each well. The emitted fluorescence is then measured for every 10 min 
over a period of 4 hr, consisting of 25 cycles in total (Fig. 3) (Kummerow, C. et al, 
unpublished). Controls used were:  
Total Target Cell fluorescence: 3×10
4
 target cells/well added to wells containing 
AIMV-HEPES. The final volume was adjusted to the same as in the experimental 
wells. These unlysed targets were taken as negative control. 
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Total lysed Target Cell fluorescence:  3×10
4
 target cells/well added to wells 
containing AIMV-HEPES. The final volume was adjusted to the same as in the 
experimental wells. 20 µl of the lysis solution (10 % Triton in AIMV-HEPES) was 
added to each well and mixed well. These Triton lysed target cells were taken as 
positive control for lysis. 
Volume Correction Control: 20 µl of above mentioned lysis solution was added to a 
triplicate set of wells containing 250 µl of AIMV-HEPES. This control was used to 
correct for the volume increase caused by the addition of the said lysis solution.  
Culture Medium Background: 250 µl of AIMV-HEPES was added to a triplicate set 
of wells.  
The loss of fluorescence of the target cells is measured as cytotoxicity which is 
analysed as the percentage of target cells lysed as follows: 
 
 
 
 
where ‘r’ is ratio of initial fluorescence of target cells treated with effectors to the 
initial total fluorescence of unlysed target cells at the beginning of the assay.     
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Figure 3: Diagramatic description of the protocol for real time killing assay 
SEA stimulated CTLs were used for as effectors and Calcein loaded Raji cells were used as target cells 
in this real time killing assay. The loss of fluorescence of the target cells was measured as cytotoxicity, 
for every 10 min over 4 hr. Fluorescence excitation wavelength used was 485 nm and emission was 
measured at 535 nm. 
 
For real time killing assays in Ringer solutions, Ringer solutions with different 
calcium concentrations were used to plate the Calcein loaded target cells (Raji cells) 
and further preceded as previously described to measure the effect of calcium on CTL 
cytotoxicity. The CTLs for different conditions were added in respective 
concentrations of calcium solutions. 
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Calcium solutions were prepared from the following stock solutions mentioned in 
table 2: 
Individual stock solutions (solns)  1 Litre 
3M NaCl 58.44 g/mol 175.32 g 
1M KCl 74.55 g/mol 74.55 g 
1M MgCl2 203.3 g/mol 203.3 g 
1M CaCl2 147.02 g/mol 147.02 g 
Table 2: Stock solutions of different reagents used in the preparation of calcium 
solutions 
 
Table 3: 0 mM, 1 mM and 10 mM calcium solution recipies 
 
Similarly other solutions with different calcium concentrations such as 31.25 µM, 
62.5 µM, 125 µM, 250 µM, 500 µM, 1 mM, 2 mM and 5 mM were prepared from the 
stock solutions mentioned in table 2. Note: The pH of the above mentioned solutions 
was adjusted to 7.4 with 1 N NaOH. 
 For  
500 ml 
 For  
500 ml 
 For  
500 ml 
0 mM Ca
2+
 soln 
pH 7.4 
 1 mM Ca
2+
 soln 
pH 7.4 
 10 mM Ca
2+
 soln 
pH 7.4 
 
155 mM NaCl 25.835 
ml 
155 mM NaCl 25.835 
ml 
155 mM NaCl 25.835 
ml 
4.5 mM KCl 2.250 ml 4.5 mM KCl 2.250 ml 4.5 mM KCl 2.250 ml 
10 mM Glucose 0.991 g 10 mM Glucose 0.991 g 10 mM Glucose 0.991 g 
5 mM HEPES 0.596 g 5 mM HEPES 0.596 g 5 mM HEPES 0.596 g 
3 mM MgCl2 1.5 ml 2 mM MgCl2 1 ml 2 mM MgCl2 1 ml 
CaCl2 nil 1 mM CaCl2 500 μl 10 mM CaCl2 5 ml 
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2.9. Cell lysate preparation for Western Blot 
0.5x10
6
 cells (siRNA transfected or untransfected CTLs) were taken in a 1.5 ml 
eppendorf tube, centrifuged at 200 g (Eppendorf-MiniSpin), 5 min, RT. Supernatant 
discarded and pellet resuspended with ice cold PBS, then centrifuged at 200 g 
(Eppendorf-MiniSpin), 5 min, RT. Pellet obtained was resuspended in 20 µl of 1 x gel 
loading buffer and stored at -20
o
C for 10-15 min (till frozen). This was then thawed to 
RT and sonicated to fully lyse the cells. These were heated at 90
o 
C for 5 min. After a 
fast spin these cell lysates were stored at -20
o
C till use. 
 
2.10. Western Blot 
Western blot analysis was used to detect our proteins of interest. 4 % (stacking) and 
12 % separating Tris-glycine gels were used for the separation of the proteins in the 
cell lysate by Bio-Rad gel electrophoresis system. The gels were run in 1x SDS buffer 
(that is prepared from 10x SDS buffer, pH 8.3). The proteins from the gel were 
electroblotted to a nitrocellulose membrane (Life Technologies) using transfer 
chamber (X-Cell SureLock
TM
, Invitrogen Novex Mini-cell) in the presence of transfer 
buffer with 195 mA current and constant voltage for 135 min. After the transfer, the 
membrane was blocked with 5 % non fat dry milk in 1x TBST (20 mM Tris, 0.15 M 
NaCl (pH 7.4) with 0.05 % Tween-20) for 30 min at RT on a tilter. Then the blot was 
washed 3 times with 1xTBST for 5 min each. Later the blot was incubated overnight 
at 4°C with primary antibody (diluted in 2 % Bovine Serum Albumin (BSA) in 
1xTBST). 
Anti human rabbit polyclonal Syntaxin 8 antibody (SynapticSystems): 1:1000 dil 
Anti human rabbit polyclonal gamma tubulin (γ-TBN) antibody (Sigma): 1:1000 dil 
Anti human rabbit polyclonal perforin antibody (SantaCruz): 1:400 dil 
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Anti human rabbit polyclonal granzyme B antibody (Cell Signalling): 1:5000 dil 
Anti human rabbit polyclonal FASL (CD178) antibody (SantaCruz): 1:100 dil 
After the incubation with a primary antibody, the blot was washed 4 times with 
1xTBST for 5 min each. Blot was then incubated with horseradish peroxidase anti-
rabbit secondary antibody (Amersham, 1:40,000 diluted in 2 % BSA in 1xTBST) for 
45 min at RT on a tilter. After washing the blot 4 times with 1xTBST for 5 min each, 
it was developed with ECL solution (1:1 mixture) (Pierce, ThermoScientific) for 1 
min and the bands developed on the blot were imaged on BioRad imaging system and 
the bands were quantified and analysed by the QualityOne, ImageJ 1.45s and Exel 
softwares. 
The different buffers used in the various stages of western blotting are: 
 
1) Sample gel (SG, Loading gel) buffer pH 6.8: 
18.905 g of 0.5 M Tris HCl 
0.96 g of 0.4 % SDS     ad 240 ml 
                                                       
2) TG Buffer (Separating gel buffer) pH 8.8: 
72.7 g of 1.5 M Trizma Base (Mol.Wt 121.14) 
      1.6 g of 0.4 % SDS (Mol.Wt 288.38) 
while dissolving (stirring) the temperature is set to 50°C pH is adjusted with HCl and 
volume is made upto 400 ml with distilled H2O. 
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3) Loading buffer: 
10 ml of 4x loading buffer is prepared with  
3.1 ml of distilled H2O  
2.4 ml of 1 M Tris HCl pH6.8 
4 ml of Glycerol 
0.8 g of 1 % SDS 
0.5 ml of ß-Mercaptoethanol 
4 mg of 1 % bromophenol blue 
When making 1X loading buffer from the above 4X buffer, 1 % (of the total volume 
of 1X buffer to be made) ß-Mercaptoethanol is added. 
 
4) 10x SDS gel buffer, pH 8.3 
30.29 g of 250 mM Trizma                       
144.15 g of 1.92 M Glycin                     
10 g of 1 % SDS                             
while dissolving (stirring) temperature is maintained at 50°C. The 1x SDS 
buffer was prepared by making dilution from the 10x SDS buffer stock with 
double distilled H2O. 
 
5) 10x Transfer buffer                           
30.0 g of Tris Base                           
144 g of Glycine                            
The volume is made upto 1000 ml with distilled H2O.  
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1x Transfer buffer is made from the 10x buffer as follows: 
100 ml 10x Transfer buffer 
200 ml Methanol 
           700 ml double distilled H2O 
 
2.11. Immunocytochemistry 
SEA stimulated CTLs were incubated with Raji cells (pulsed with 10 μg/ml of SEA at 
37°C for 30 min) at 37°C for different time points on glass coverslips coated with 0.1 
mg/ml poly-Ornithine for 20 min. For resting cells, only CTLs without the target calls 
were plated on the coverslips. Cells were resuspended in a volume of 50 µl for one 
coverslip. Cells were fixed in ice cold 4 % PFA (freshly prepared from 10 % PFA 
stock by dilution with PBS (GIBCO)) for 20 min at RT 
45
. After which the PFA is 
removed from the cover slips and the cells were washed with 0.1 M Glycine (prepared 
in PBS) for 3 min at RT to remove excess PFA. The cells were washed thrice with 
PBS for 5 min each. The cells were then permeabilized, before staining with primary 
and secondary antibodies, with PBS+0.1 % Triton for 20 min at RT and later blocked 
at RT with blocking buffer (PBS with 0.1 % Triton+2 % BSA) for 30 min at RT. All 
the primary antibodies and secondary antibodies used were diluted in this blocking 
buffer. The cells were incubated with primary antibody at RT for 90 min, then washed 
3 times with PBS+0.1 % Triton for 5 min each and later incubated with the secondary 
antibody for 45 min at RT. Various proteins were stained using different antibodies. T 
cell receptors (TCR) were labelled with Alexa
488
- or Alexa
647
- labelled anti-CD3 mAb 
(UCHT1, Biolegend), lytic granules (LG) with Alexa
647
- labelled anti-perforin mAb 
(dG9, Biolegend), lysosomes (representing late endosomes) with Alexa
488
- labelled 
anti-LAMP1 mAb (H4A3, Biolegend) and early endosomes with mouse anti-EEA1 
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mAb (BD Biosciences). Rab7 constructs (transfected in CTLs) were used as late 
endosome markers. Endogenous Syntaxin8 was labelled with rabbit polyclonal anti-
Syntaxin8 antibody (Synaptic Systems). Alexa
568
-, Alexa
647
-labelled goat-anti-rabbit 
or Alexa
568
-, Alexa
488
-labelled goat-anti-mouse secondary antibodies (Life 
Technologies) were used accordingly. After the secondary antibody incubation, the 
cells were washed thoroughly with PBS+0.1 % Triton twice for 5 min each and the 
last wash for 5 min with PBS. Coverslips were removed from PBS and carefully 
mounted with 3 µl mounting medium per coverslip, onto pre cleaned glass slides. The 
mounted glass slides were stored in dark at 4°C till further use for imaging. 
In some cases, the control and Syntaxin 8 downregulated CTLs were incubated with 
CHX (Cycloheximide) and DMSO for 4 hr at 37°C and later used for fixing and 
staining. After mounting the cells, these were stored at 4°C until scanning. 
Solutions used here as prepared as follows: 
 
1) 10 % PFA stock solution in PBS: 
            10 ml of 16 % Formaldehyde (ultrapur, polysciences Inv) 
            1.6 ml of 10x PBS (Gibco) 
            4.1 ml doubledistilled H2O 
pH was set to 7.4.and sterile filtered and stored at -20
0
C after making aliquots. 4 % 
PFA was made just before use by diluting the 10 % PFA stock in PBS 
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2) Mounting medium 
6 g of Glycerol was added to a 50 ml falcon tube to which 2.4 g Mowiol 4-88 was 
added and vortexed well. To this 6 ml double distilled water was added and let to 
stand for 2 hr at RT. Then 12 ml of 0.2 M Tris buffer (pH 8.5) was added and 
incubated at 53
o
C till the Mowiol is dissolved. This was mixed well from time to time 
and then centrifuged at 4000 - 5000 rpm for 20 min. The supernatant was aliquoted 
and stored at -20
o
C. 
 
2.12. Epifluorescence deconvolution microscopy and analysis 
Epifluorescence microscopy with subsequent deconvolution of the immunostained 
cell samples was done with Zeiss Cell Observer HS system with a 100x αPlan-Fluar 
objective (N.A. 1.45) and an AxioCam MRm Rev. 3. Images were acquired with a z-
stepsize of 0.2 m and 2  2 binning. Deconvolution with Classic Maximum 
Likelihood Estimation (CMLE) algorithm by Huygens Professional software was 
performed using a point spread function calculated with the z-stack acquisition from 
170 nm yellow-green, orange or deep-red fluorescent beads (PS-Speck, Life 
Technologies). These image files were then converted to tif images and if necessary 
edited with ‘Resample’ function of the AxioVision software to correct any pixel shifts 
present in the obtained images with respect to the fluorescent beads mentioned above. 
Later ImageJ 1.45s software was used to generate merged images and projections of 
stacks. For analyzing colocalization, Pearson’s coefficient correlation factor was 
analysed using an ImageJ 1.45s plugin called Just Another Colocalization plugin 
(JACoP). The dependency and correlations of pixels from two channels are measured 
by Pearson’s coefficient analysis. The fluorescence intensity of a pixel from one 
channel is plotted against the fluorescence intensity of a pixel from another channel to 
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form a scatter plot. The slope of this linear plot provides the rate of association of the 
two fluorophores. Pearson’s correlation coefficient is the measure of strength of linear 
relationship between the two variables, which are the two pixels from two different 
channels. The value of the Pearson’s coefficient factor ‘r’ can range from 1 to -1 with 
1 for complete positive correlation of association and -1 for negative correlation and 0 
for no correlation. 
3D analysis of the perforin vesicles was done using the Axio vision 3D view software, 
where the scanned images were set to a low threshold for background correction to 
eliminate the noise and 3D measured for the selected channel (corresponding to the 
required wavelength) to obtain the volume of selected ROIs which represent the 
perforin vesicles. 
 
2.13. anti-CD3/CD28 antibody prestimulation of CTLs 
 In a 24 well plate, each wells were coated with 200 μl of 1:1,500 dil (in PBS) rabbit 
polyclonal anti-mouse immunoglobulin (DAKO, Cat. No: Z0259) for 1.5 hr at 37°C 
and stored in PBS overnight at 4°C. Then they are washed twice with 1 ml PBS at RT 
and later they were incubated with 4 g/ml each (prepared in PBS) of mouse anti-
CD3 Ab (AbD seroTec, Cat. No: MCA463EL) and mouse anti-CD28 Ab (BD 
Pharmingen
TM
, Cat. No: 555725) at 37°C for 1.5 hr. These wells were washed once 
with PBS.  The pre existing perforin store was depleted from control and Syntaxin 8 
downregulated CTLs by plating 2x10
6
 cells/ml in the Ab treated wells for 2 hr at 
37°C. Then the cells were transferred to fresh wells without any Ab and are allowed 
to recover in AIMV + 10 % FCS with 20 U/ml IL-2 for 6 hr or 24 hr at 37°C. 
 
2. Materials and Methods 
 
44 
 
2.14. Perforin ELISA 
Control and Syntaxin 8 downregulated CTLs were first depleted of their preexisting 
perforin store by anti-CD3 / anti-CD28 Ab stimulation for 2 hr at 37°C. Then the cells 
were transferred to fresh wells without any Ab and are allowed to recover for 6 hr at 
37°C as mentioned previously. After recovery, these cells were again incubated in 
anti-CD3 / anti-CD28 Ab pretreated wells (of a 96 well plate, BD Biosciences) in 
AIMV + 10 % FCS at 37°C for different time points after which the supernatants 
were collected from these into individual eppendorf tubes. These were centrifuged at 
200 g at RT for 5 min and supernatants were collected into fresh eppendorf tubes and 
stored at -20°C until further use. The supernatants collected were thawed to RT and 
analysed for perforin using the perforin ELISA kit (Diaclone) as per the 
manufacturer’s instructions. Perforin ELISA was also conducted for supernatants 
collected from CTLs which were not emptied of their pre-existing perforin pool. 
These CTLs were conjugated with either Raji cells as target cells or with anti-CD3 / 
anti-CD28 Ab coated activator beads (Life Technologies). 
The different time points for preparation of the ELISA samples (after depletion of 
pre-existing perforin pool) are as follows: 
Resting (or time zero, where the CTLs are incubated with target cells for 5 min and 
supernatant collected), 8 hr, 16 hr, 20 hr and 24 hr. Resting, 24 hr and 48 hr were the 
time points for ELISA samples without depleting pre-existing perforin pool. 
 
2.15. FACS analysis 
Fluorescence-activated cell sorting (FACS) is a flow cytometry technique which can 
be used for sorting cells, counting and analyses of microscopic particles. Multiple 
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physical and chemical parameters can be measured simultaneously by this technique, 
thousands of cells can be measured within minutes. 
CTLs that were either depleted (using the anti-CD3 / antiCD28 Ab treatment) or not 
depleted of their preexisting perforin pool were incubated in anti-CD3 / anti-CD28 
coated wells for different time points (like resting condition, 30 min, 2 hr, 3 hr, 4 hr 
and overnight conjugation). After each time point they were resuspended and 
collected for the assay. CTLs collected for the analysis are centrifuged at 200 g, 6 min 
at RT to remove the culture media and pellet obtained was washed with 1 ml PBS / 
0.5 % BSA (Buffer 1) solution and centrifuged again to collect the pellet. The cells in 
the pellet were then vortexed for a few seconds and incubated with 4 % PFA (200 μl 
for 0.5 x 10
6
 cells) for 15 min in ice, in the dark. After removing the PFA, the cells 
were washed 2 times with 200 μl wash buffer (PBS / 1 % FCS and 0.1 % NaN3 (pH 
7.4 – 7.6)). This was centrifuged at 690 g, 5 min, RT. Pellet obtained was resuspended 
in 1X 200 μl permeabilizing buffer (PBS / 1 % FCS +0.1 % Saponin (pH 7.4 – 7.6)) 
and centrifuged again at 690 g, 5 min, RT. Then these cells were fixed in 100 μl 
permeabilizing buffer and stained with 10 μl (per 0.5 x 106 CTLs) of FITC labelled 
mouse monoclonal perforin antibody (clone: dG9, BioLegend, Cat. No: 308103) or 
FITC labelled mouse IgG2b, κ Isotype Ctrl antibody (clone: MPC-11, BioLegend, 
Cat. No: 400309) and incubated at RT for 30 min in dark. These cells were then 
centrifuged at 690 g for 5 min at RT. The washing of the cells with permeabilizing 
buffer is repeated twice and centrifuged at 690 g for 5 min at RT. Supernatant was 
discarded, stained and fixed cells were resuspended in 200 μl PBS for further FACS 
analysis. BD Canto FACS analyser was used to analyze the perforin expressed in 
CTLs. Effector CTL population was gated and cells within these gates were analysed 
for perforin expression (FITC labelled mouse monoclonal perforin Ab) against an 
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isotype control labelled with FITC labelled mouse IgG2b monoclonal antibody using 
FlowJo software. Further analysis of the data was done using the FlowJo software, by 
gating the IgG control by setting a certain threshold % value and accepting all the 
values that exceeded this threshold in the FITC- A perforin labelled samples as the 
actual perforin fluorescence. These were represented as peaks plotted on a graph with 
FITC-A perforin labelling on the x-axis and counts (number of cells) on the y-axis. 
This gives us an idea of the number of cells labelled and also gives a rough 
quantification of the perforin content of the cell by giving us the perforin fluorescence 
intensity in these measured cells. 
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3. RESULTS 
 
3.1. Syntaxin 8 is localized mainly in late and recycling endosomes and partially 
with lytic granules, TCR, Vti1b which are essential for normal CTL function 
 
3.1.1. Syntaxin 8 is partially colocaized with lytic granules, TCR and Vti1b  
SNAREs proteins, the members of intracellular trafficking pathway are known to be 
required for normal human CTL function 
45,98,131
. Apart from Vti1b and Syntaxin 7, 
which are shown to be directly involved in CTL functions, several other SNAREs like 
Syntaxin 8, Syntaxin 11 are also enriched at the immunological synapse (IS), 
indicating that they could play essential roles in CTL cytotoxicity 
98
. As no Qc- 
SNARE has been identified to be directly involved in CTL function, we set out to 
examine the significance of Syntaxin 8 in human CTL function. It has already been 
shown by us that Syntaxin 8 is expressed in both primary human naïve CD8
+
 T cells 
and activated CTLs 
1
. To study the function of Syntaxin 8 in CTL, we examined the 
sub-cellular localization of Syntaxin 8. SEA stimulated CTLs were conjugated with 
SEA pulsed Raji cells 
129
, fixed with PFA and later stained with CD3 Ab for labelling 
TCR (Fig. 4A), perforin Ab to label the lytic granules (Fig. 4B) and Syntaxin 8 Ab for 
labelling Syntaxin 8. These fixed samples were then scanned with epifluorescence 
deconvolution microscopy. The images obtained were deconvolved and anlysed for 
extent of colocalization by measuring the Pearson’s co-efficient using JACoP function 
of ImageJ 1.45s.  
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The result showed that Syntaxin 8 partially colocalized with both TCR and lytic 
granules with Pearson’s co-efficient of 0.596 ± 0.02 (Fig. 4A) and 0.481 ± 0.03 (Fig. 
4B), respectively. We also found that Syntaxin 8 accumulated at the mature IS 
(indicated by enrichment of CD3 and lytic granules at the contact site facing the 
targets).  As TCR activated CTLs kill their targets by release of lytic granules, both 
TCR and lytic granules are the functional components of a CTL. Therefore this 
finding, that Syntaxin 8 colocalizes with TCR and lytic granules, implies its 
involvement in the CTL functioning.  
As Vti1b is required for the lytic granule and TCR tethering which facilitates the 
docking of lytic granules at the IS 
45
, we further investigated the localization of 
Syntaxin 8 and Vti1b. We observed that in resting CTLs, both Vti1b and Syntaxin 8 
are dispersed throughout the cell whereas in conjugated CTLs both proteins 
accumulate at the IS. Furthermore Syntaxin 8 partially colocalizes with Vti1b in both 
resting and conjugated CTLs with a Pearson’s co-efficient of 0.41 ± 0.02 and 0.45 ± 
0.05 in resting and conjugated CTLs, respectively (Fig. 4C). These results indicate 
that Syntaxin 8 may be important for the normal functioning of CTLs.  
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Figure 4: Syntaxin 8 partially colocalizes with TCR, lytic granules and Vti1b. 
SEA stimulated CTLs were incubated with SEA pulsed Raji cells for 30 min at 37
o
C before fixation 
with ice-cold 4 % PFA. After permeabilizing these cells, Syntaxin 8 was labelled with rabbit polyclonal 
anti-Syntaxin 8 Ab; Alexa
568
 conjugated secondary goat anti-rabbit Ab (red). (A) TCR was labelled 
with Alexa
647
 conjugated anti-CD3 Ab (green), and (B) lytic granules with Alexa
647
 conjugated anti-
perforin Ab (green).  (C) Vti1b was labelled with mouse monoclonal anti-Vti1b Ab, Alexa
488
 
conjugated secondary goat anti-mouse Ab (green). Scale bar = 3 µm. In each condition 10 cells were 
analysed for Pearson’s coefficient (PC) [1 = complete co-localization, 0 = no co-localization]. MIP: 
Maximum Intensity Projection.     
                       
3.1.2. Syntaxin 8 is mainly localized in late endosomal and recycling endosomal 
compartments in CTLs 
In order to further nail down the sub-cellular localization of Syntaxin 8 in CTLs, we 
examined the colocalization of Syntaxin 8 with early, late, recycling and lysosomal 
compartments, which were labelled with EEA1, Rab7-mCherry, Rab11-mCherry and 
LAMP1, respectively in both resting CTLs and CTLs conjugated with target cells. We 
found that Syntaxin 8 is mainly colocalized with the late lysosomal compartment 
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marker Rab7 in both resting and conjugated cells, with Pearson’s coefficient of 0.72 ± 
0.02 (resting cells) and 0.67 ± 0.01 (conjugated cells), (Fig. 5A, 6A) respectively. In 
resting cells we observed puncta like membranous distribution of both Syntaxin 8 and 
Rab7 mCherry (Fig. 5A) whereas in conjugated cells both the proteins are 
accumulated at the IS (Fig. 6A). Syntaxin 8 also colocalizes with LAMP1, a marker 
for lysosomal compartment with Pearson’s co-efficient of 0.58 ± 0.01 for resting 
cells(Fig. 5C) and 0.63 ± 0.01 for conjugated CTLs (Fig. 6C) and with Rab11-
mCherry which is a marker for recycling endosomes with Pearson’s co-efficient of 
0.73 ± 0.02 for resting CTLs (Fig. 5D) and 0.65 ± 0.03 for conjugated CTLs (Fig. 
6D). In contrast to this a comparatively lower Pearson’s co-efficient of 0.24 ± 0.01 for 
resting cells (Fig. 5B) and 0.35 ± 0.02 for conjugated cells (Fig. 6B) was observed 
with early endosome marker EEA1. Even though we see the accumulation of 
Syntaxin 8 at the IS, EEA1 does not accumulate at the IS in conjugated CTLs. In spite 
of lower overlapping of Syntaxin 8 in early endosomes than in late endosomes, the 
Pearson’s co-efficient for early endosomes (in conjugated cells) is quite good and is 
considered as partial colocalization. By this we can conclude that Syntaxin 8 is 
localized mainly in the late endosomal compartments and in recycling endosomes and 
to a lesser extent in early endosomes of conjugated CTLs. The colocalization of 
Syntaxin 8 in lysosomal compartments and the other endosomal compartments 
indicates that it may participate in the trafficking of lytic granule components like 
perforin and granzymes to the lysosomal (lytic granule) compartments. 
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Figure 5: Syntaxin 8 localization in endosomal compartments in resting CTLs. 
Syntaxin 8 labelled with rabbit polyclonal anti-Syntaxin 8 Ab, Alexa
647
 conjugated goat anti-rabbit 
secondary Ab (green) with different endosomal compartment markers. In resting CTLs. (A) Late 
endosomes were labelled with Rab7-mCherry construct (B) Early endosomes with  mouse monoclonal 
anti-EEA1 primary Ab and Alexa
568
 conjugated goat secondary anti-mouse Ab (red) (C) Lysosomal 
compartments were labelled with Alexa
488
 conjugated LAMP1 (CD107) mouse monoclonal Ab (red). 
In each condition (Figs. A,B,C) 30 cells were analysed for Pearson’s coefficient. (D) Recycling 
endosomes were labelled with Rab11-mCherry construct (red) and n = 6 cells for this condition. Scale 
bar = 3 µm.  
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Figure 6: Syntaxin 8 localization in endosomal compartments in CTLs conjugated with targets. 
Syntaxin 8 labelled with rabbit polyclonal anti-Syntaxin 8 Ab, Alexa
647
 conjugated goat anti-rabbit 
secondary Ab (green) with different endosomal compartment markers in SEA stimulated CTLs that are 
conjugated with SEA stimulated Raji cells for 30 min at 37
o
C. (A) Late endosomes were labelled with 
Rab7-mCherry construct, (B) early endosomes with mouse monoclonal anti-EEA1 primary Ab and 
Alexa
568
 conjugated goat secondary anti-mouse Ab (red). (C) The lysosomal compartments were 
labelled with Alexa
488
 conjugated LAMP1 (CD107) mouse monoclonal Ab (red). In each condition 
(Figs. A,B,C) 30 cells were analysed for Pearson’s coefficient. (D) Recycling endosomes were labelled 
with Rab11-mCherry construct (red) and n = 12 cells. Scale bar = 3 µm. 
 
3.2. Syntaxin 8 is required for CTL cytotoxicity 
3.2.1. Syntaxin 8 is efficiently downregulated in primary human CTLs by siRNA 
transfection 
To understand the mechanisms by which Syntaxin 8 influences CTL cytotoxicity, we 
used siRNA to downregulate Syntaxin 8 in primary human CTLs. Using 
nucleofection with Lonza technology, we managed to achieve transfection efficiency 
of 97.5 ± 2.5 % (n = 3, mean ± SEM) of Alexa
546
-labelled control siRNA (Fig. 7A).  
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To optimize the downregulation of Syntaxin 8, first we checked four Syntaxin 8 
siRNA that are targeted against different regions of Syntaxin 8 mRNA. A scrambled 
unspecific siRNA was used as the control. Two out of the four siRNAs showed good 
downregulation at mRNA level, of which Sxt8_5 showed the highest downregulation 
(Fig. 7B). It is reported that a stable OMe- modification of siRNA can substantially 
prolong half-life of siRNA in primary T cells by stabilizing its structure 
127
. Using this 
feature we modified Syntaxin 8 siRNA (Stx8_5) to maximize the downregulation of 
Syntaxin 8 (if not specified, the following used Syntaxin8 siRNA are modified 
Stx8_5). To determine the optimal time point of Syntaxin 8 downregulation, we 
collected siRNA transfected CTLs at various time points. Quantitative RT-PCR 
showed that Syntaxin 8 could be efficiently downregulated and only about 15 % of 
the mRNA could be detected between 12 to 36 hr after transfection (Fig. 7C). To 
balance between downregulation efficacy and effector status of CTLs, we chose 36 hr 
for the following functional experiments. Subsequently, western blot was carried out 
to confirm downregulation at protein level at 36 hr after transfection, which showed 
75.1 % ± 3.8 % downregulation at protein level (Fig. 7F, 7G). The downregulation 
was further confirmed by immunocytochemistry which showed reduced Syntaxin 8 
protein staining in Syntaxin 8 siRNA CTLs compared to control CTLs (Fig. 8A). The 
specificity of Syntaxin 8 siRNA was verified with the expression level of two other 
mRNAs, Vti1b and perforin, in Syntaxin 8 downregulated CTLs. It showed that only 
Syntaxin 8 and not Vti1b or perforin was downregulated by Stx8-5 siRNA (Fig. 8B). 
On the whole, 36 hrs after transfection is the time point optimized for downregulation 
and subsequent functional studies. 
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Figure 7: Syntaxin 8 is efficiently downregulated at both mRNA and protein levels by modified 
Syntaxin 8 siRNA (Stx8-siRNA). 
Primary human CTLs were transfected efficiently with siRNA. (A) CTLs were transfected with 
Alexa
546
-conjugated siRNA and control non-fluorescent siRNA. The transfection efficiency detected 
was 97.5 ± 2.5 % (n = 3, Mean ± SEM). (B) Four unmodified Stx8-siRNAs were tested for 
downregulation of Syntaxin 8 in primary human CTLs. Scrambled siRNA was used as control siRNA 
(Ctrl-siRNA). Stx8_5 (Syntaxin 8_5) showed the highest downregulation. (C) Optimization of the time 
point for the down-regulation. OMe- modified Stx8_5 siRNA was used to determine the 
downregulation efficiency at different time points after transfection. The down-regulation of Syntaxin 8 
at 36 hr after transfection at (C) mRNA and (D,E) protein levels  (n = 3, Mean ± SEM). (D) Western 
blot analysis of the proteins showed a band at 27 kDa for Syntaxin 8 protein and a band at 48 kDa for 
loading control γ Tubulin. Densitometry of the protein expressed in the western blot is shown in Fig. E. 
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Figure 8: Syntaxin 8 is efficiently and specifically downregulated by modified Syntaxin 8 siRNA 
(Stx8-siRNA). 
(A) Immunocytochemistry of control (Ctrl-) and Syntaxin 8 (Stx8- siRNA) si-RNA transfected CTLs 
showed efficient downregulation of Syntaxin 8, were Syntaxin 8 was labelled with rabbit polyclonal 
anti-Syntaxin 8 Ab and Alexa
568
 conjugated goat anti-rabbit secondary Ab. (B) Specificity of Stx8-
siRNA was verified by testing the downregulation of Syntaxin 8, Vti1b and perforin in CTLs 
transfected with modified Ctrl- and Stx8_5-siRNA (n = 3, Mean ± SEM). 
 
3.2.2. CTL mediated cytotoxicity is impaired by Syntaxin 8 downregulation 
The ultimate read out for normal CTL functioning is its cytotoxicity efficiency. This 
can be measured at single cell level or at population level. The single cell level 
cytotoxicity can be measured by different microscopy techniques using fluorescent 
dyes, visualizing single killing events directly. However population killing assay 
offers an overview of the overall killing competence of CTLs at defined conditions, 
thus enabling the quantification of CTL cytotoxicity function. All the population 
killing assays reported till now are the end point analysis assays, in which only the 
end point or the time point at the end of the complete experiment can be measured. 
The most used end point killing assays are lactate dehydrogenase (LDH) release assay 
132
 and 
51
Cr release assay 
133
. These two assays measure the activity of LDH or 
51
Cr, 
which are released from lysed target cells into the supernatant, 4 hours after the 
incubation. 
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We used a new technique developed in our lab, called the real-time killing assay, to 
measure the killing capacity of CTLs in real time. In this assay calcein-loaded target 
cells are measured every 10 min for 4 hr at 37
o
C, with the excitation and emission 
wavelength of 485 nm and 535 nm, respectively (Kummerow, C. et al, unpublished). 
In order to reflect the true killing event, we optimized the conditions for the media. 
We tried AIMV with (Fig. 9A) and without FCS (Fig. 9B). We found that though the 
same badge of effector and target cells were used, it showed different killing kinetics 
for AIMV with FCS (Fig. 9A) and without FCS (Fig. 9B). We further verified with 
high-content image setup BioImager that real-time killing assay done in AIMV 
without FCS represents the killing events at single cell level (Kummerow, C. et al, 
unpublished). 
This assay was also tested with other media such as Ringer solutions with different 
calcium concentrations (Ca
2+
 conc)   using different effector to target ratios (20:1 and 
10:1) (Fig. 10). 
In AIMV + FCS condition we found a final killing of 64.33 ± 3.54 % at 20:1 effector 
to target ratio. We also observed a gradual increase in target lysis over time (Fig. 9A). 
Whereas in AIMV no FCS condition, a much higher final killing of 91.33 ± 5.27 % at 
20:1 effector to target ratio was observed. Also the increase in the target lysis is quite 
rapid even at the initial phase compared to that in AIMV+FCS condition (Fig. 9B). 
The 8 different Ca
2+
 conc used for CTL killing showed varied killing efficiencies. We 
showed an increase in the killing efficiency with increase in Ca
2+
 conc from 32.5 µM 
Ca
2+
 to 500 μM Ca2+ but at 250 μM Ca2+, killing efficiency was the highest. Killing 
efficiency kept decreasing on increasing the Ca
2+
 concs to 1, 2 and 5 mM (Fig. 10). 
These results indicate the Ca
2+
dependency of CTLs for their cytotoxicity. 
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To study the perforin killing pathway in CTLs, we blocked the H+ ATP hydrolase 
enzyme in CTL lytic granules by an inhibitor called conconamycin A (CMA) which 
compromises the acidic pH of the lytic granules by increasing the pH 
134
. As an acidic 
environment is required to keep perforin and granzymes inactive by binding to 
proteoglycans, the increase in the pH degenerates these molecules. Another possibility 
is that the increase in the pH leads the activated granzymes and other proteases in the 
lytic granules to cleave and degrade the lytic granule contents thus blocking the lytic 
granule function. CTLs were treated with various concentrations of CMA for 2 hr at 
37
o
C; DMSO was used as a solvent control. To rule out the possibility that the target 
(Raji) cells were affected by the CMA, we included controls of calcein loaded targets 
incubated with and without the CMA (highest concentration used), throughout the 4 
hr time frame of the assay, which showed that the targets were unaffected by the 
CMA. We observed that CMA treatment blocks mainly the lytic granule pathway 
which can be seen by the concentration dependent reduction in cytotoxicity when 
compared to the cytotoxicity of CTLs treated with DMSO (Fig. 11). This strongly 
suggests that the major cytotoxic pathway in human CTLs is the perforin dependent 
lytic granule pathway. 
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Figure 9: Real time Calcein killing assay. 
(A) Real time Calcein killing assay using SEA stimulated CTLs and SEA pulsed Raji cells as targets 
was performed at 20:1 and 10:1 effector to target ratio in AIMV media with 10 % FCS. Total number 
of experiments, n = 10. (B) The same assay was performed again in AIMV media without FCS at 20:1 
and 10:1 effector to target ratio. Total number of experiments, n = 4, Mean ± SEM. Fluorescence 
excitation wavelength used was 485 nm and emission was measured at 535 nm. Fluorescence measured 
for every 10 min over a period of 4 hr at 37
o
C. 
 
 
Figure 10: Calcium dependency of CTL mediated  cytotoxicity. 
Real time Calcein killing assay using SEA stimulated CTLs at 10:1 effector to target ratio in Ringer 
solutions with different Ca
2+
 concs (31.25 μM, 62.5 μM, 125 μM, 250 μM, 500 μM, 1 mM, 2 mM and 
5 mM). Fluorescence excitation wavelength used was 485 nm and emission was measured at 535 nm. 
Fluorescence measured for every 10 min over a period of 4 hr at 37
o
C. 
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Figure 11: Effect of different CMA concentrations on CTL cytotoxicity. 
CTLs treated with various concentrations (50 nM, 10 nM, 5 nM, 2 nM, 1 nM, 0.5 nM, 0.25 nM, 0.05 
nM and 0.01 nM) of conconamycin A (CMA) were used in real time killing assay at 20:1 effector to 
target ratio in AIMV without FCS. Fluorescence excitation wavelength used was 485 nm and emission 
was measured at 535 nm. Fluorescence measured for every 10 min over a period of 4 hr at 37
o
C 
 
Since Syntaxin 8 accumulated at the IS upon the recognition of target cells, we 
proceeded to determine if Syntaxin 8 is involved in CTL mediated cytotoxicity. Thus 
we downregulated this protein and checked if it effected the cytotoxicity efficiency of 
human CTLs. 36 hr after transfection with control or Syntaxin 8 siRNA, CTLs were 
used in real time killing assay. We found that, compared to the control CTLs, 
Syntaxin 8 downregulated CTLs showed reduced killing In killing assays, where 
CTLs in AIMV media with FCS were used, we start observing the difference in 
cytotoxicity of control and Syntaxin 8 downregulated CTLs from 60 min onwards but 
the difference between them is significant from 150 min onwards (Fig. 12A). Even in 
AIMV media without FCS, we see reduced killing by Syntaxin 8 downregulated 
CTLs compared to control CTLs. In this the killing is rapid even at the initial time 
points and the difference in killing between control and Syntaxin 8 downregulated 
CTLs is more evident from 100 minutes onwards (Fig. 12B). 
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Real time killing assay with Vti1b downregulated CTLs (which showed reduced 
cytotoxicty by LDH assay 
45
, was performed as positive control for cytotoxicity where 
we observed a reduction in cytotoxicity in Vti1b downregulated CTLs compared to 
the control CTLs (Fig. 13A). 
To rule out the possibility that the cytotoxicity was affected by SNARE protein 
downregulation in general, we checked the target lysis in Syntaxin 6 (Stx 6) 
downregulated CTL, since Syntaxin 6 is also a Qc- SNARE like Syntaxin 8. We 
found no change in cytotoxicity by downregulation of Syntaxin 6 (Fig. 13B). These 
results suggest that Syntaxin 8 is involved in CTL cytotoxicity. 
 
 
Figure 12: Syntaxin 8 downregulation impairs CTL cytotoxicity. 
Real time killing assay using Ctrl-siRNA (control) and Stx8-siRNA (Syntaxin 8) CTLs with SEA 
pulsed Raji cells at 20:1 effector to target ratio showed that cytotoxicity of CTLs is reduced on Stx8 
downregulation. The medium used for the assay is AIMV with 10 % FCS. SEA stimulated control and 
Syntaxin 8 siRNA transfected CTLs were used in this assay 36 hr after transfection. The results are 
shown as Mean ± SEM (n = 10, * = P < 0.05, ** = P < 0.01 and *** = P < 0.001). Fluorescence was 
measured for every 10 min over a period of 4 hr at 37
o
C. 
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Figure 13: Vti1b and Stx 6 downregulated CTLs used as controls for CTL cytotoxicity. 
(A) 36 hr after transfection of modified Vti1b-siRNA and Ctlr-siRNA in CTLs, real time killing assay 
was conducted with a total number of experiments, n = 6, Mean ± SEM. (B) 36 hr after transfection of 
unmodified Stx6-siRNA (Syntaxin 6) and Ctlr-siRNA in CTLs, real time killing assay was conducted. 
Total number of experiments, n = 5, Mean ± SEM. Fluorescence measured for every 10 min over a 
period of 4 hr at 37
o
C. 
 
3.3. Syntaxin 8 downregulation does not inhibit exocytosis of lytic granules in 
CTLs 
3.3.1. Decrease in perforin released by Syntaxin 8 downregulated CTLs results 
after emptying their preexisting cytotoxic molecule pool 
To confirm if exocytosis of lytic granules is impaired by Syntaxin 8 downregulation, 
we analysed perforin secretion. This was examined by detecting the amount of 
perforin released to the supernatant upon CTL-target recognition using ELISA. CTLs 
were incubated with target cells like Raji cells (Fig. 14A) or CD3 / CD28 activator 
beads (Life Technologies) (Fig. 14B). The supernatant was collected at different times 
as indicated in the figures. We found that there was no significant change in the levels 
of perforin exocytosed by Syntaxin 8 downregulated CTLs (Fig. 14A, 14B). It implies 
that Syntaxin 8 might not have an impact on lytic granule release per se.  
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Next we were wondering whether Syntaxin 8 may play a role in the generation or 
sorting of new lytic granules. To address this question we depleted the pre-existing 
lytic granule pool by incubating the control and Syntaxin 8 downregulated CTLs in 
96-well plates coated with anti-CD3 / anti-CD28 antibodies for 2 hr at 37
o
C. Once the 
pre-existing pools were depleted, these cells were kept in the incubation to recover for 
6hr in fresh uncoated wells. Then the cells were again incubated with anti-CD3 / anti-
CD28 antibodies (now to mimic the target cells) for various time points. The 
supernatant for ELISA were collected at each of these time points as indicated in the 
figure. We found that there was no significant difference in the perforin release at the 
initial time points, 0 hr and 8 hr; whereas at later time points (16, 20, 24 and 48 hr) the 
difference in perforin release was significant between control and Syntaxin 8 down-
regulated CTLs (Fig. 15). It suggests that Syntaxin 8 is likely involved in steps prior 
to exocytosis like regulation in the synthesis of new cytotoxic proteins or in sorting 
and delivery of cytotoxic molecules into functional lytic granules through the 
endosomal pathway.  
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Figure 14: Control (Ctrl-) and Syntaxin 8 (Stx8-siRNA) CTLs without depletion of the 
preexisting lytic granule pool showed no significant difference  in perforin release.  
Perforin was measured by ELISA (Diaclone) in samples collected from siRNA transfected CTLs which 
were incubated with (A) Raji cells or (B) CD3 / CD28 activator beads (Life Technologies) for various 
time points at 37
o
C. These CTLs were not depleted of their preexisting lytic granule pool. n = 3, Mean 
± SEM. 
 
 
Figure 15: Syntaxin 8 downregulated CTLs show reduced perforin release on preexisting lytic 
granule pool depletion.  
After releasing the preexisting lytic granule pool by anti-CD3/anti-CD28 Ab treatment and recovery, 
Ctrl and Stx8-siRNA transfected CTLs were incubated with anti-CD3/anti-CD28 Abs, mimicking 
target cells, for different time points at 37
o
C. Perforin ELISA (Diaclone) was used to detect perforin 
concentration in the samples collected from these CTLs. n = 3, Mean ± SEM (*  P < 0.05). 
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3.3.2. Depletion of preexisting cytotoxic molecules increases the difference in 
cytotoxicity between the control and Syntaxin 8 downregulated CTLs 
Along this line, we postulated that pre-depletion of the existing lytic granule pool 
could result in more substantial reduction in CTL-mediated killing by Syntaxin 8 
down-regulation. To verify this, we performed real-time killing assay. The 
preliminary experiments with these conditions showed that indeed after the release of 
preexisting lytic granule pool, Stx8 down-regulated CTLs showed much lower 
cytotoxicity than the control CTLs (Fig. 16). We observed that there is an increase in 
the difference in cytotoxicity between control and Syntaxin 8 downregulated CTLs 
until 100 min but during the later time points the difference in cytotoxicity of 
antibody treated Syntaxin 8 and control CTLs is similar to that of antibody untreated 
CTLs. This also shows that not the lytic granule exocytosis itself but some other 
process upstream to exocytosis is affected, thus indirectly affecting and delaying the 
exocytosis.   
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Figure 16: Increased reduction in cytotoxicity of Stx8-siRNA CTLs observed on depletion of 
preexisting pool of cytotoxic molecules. 
Preliminary data of real time killing assay with control (Ctrl) and Stx 8 siRNA CTLs at 10:1 effector : 
target, in 1 donor with and without depletion of preexisting pool of cytotoxic molecules. The 
preexisting pool is emptied by treatment with anti-CD3/anti-CD28 Ab for 2 hr and allowed to recover 
overnight at 37
o
C in AMIV+10 % FCS.  
 
3.4. Syntaxin 8 is involved in production and sorting of cytotoxic molecules to 
releasable lytic granules 
 
3.4.1. Syntaxin 8 affects CTL cytotoxicity by influencing processes upstream of 
exocytosis of lytic granules 
To identify which step of the cytotoxicity process is regulated by Syntaxin 8, we 
conducted the following experiments. First we inhibited the synthesis of new proteins 
in CTLs using cycloheximide (CHX), a protein synthesis inhibitor, which inhibits the 
protein elongation process 
135
. First of all we tested the dose dependence of CHX, to 
check the optimal concentration suitable for our assay. At 10 µg/ml concentration of 
CHX the killing was inhibited after 60 min but not at the initial phase, which indicates 
that at this concentration most likely the synthesis of cytotoxic proteins was mainly 
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blocked but the killing machinery (transportation, exocytosis and so on) was still 
functioning, (Fig. 17A). Therefore we chose this concentration of 10 µg/ml for further 
experiments. DMSO was used as the solvent control in these experiments. We 
incubated the SEA stimulated Syntaxin 8 and control siRNA transfected CTLs with 
CHX and DMSO for 4 hr at 37
o
C.  
The cytotoxicity of these CHX and DMSO treated CTLs was measured using the real 
time killing assay. As expected, the positive control, DMSO treated control CTLs 
showed highest killing as neither the protein synthesis nor Syntaxin 8 levels are 
affected. A significant difference in cytotoxicity of DMSO treated control CTLs and 
CHX treated control CTLs was observed from 30 min onwards. There was significant 
reduction of cytotoxicity between Stx8-DMSO and Ctrl-DMSO (10 min, 20 min = *, 
80 to 120 min = *, 130 to 170 min = **, 180 to 220 min = ***, 230 and 240 min = 
**), Ctrl-DMSO and Ctrl-CHX (30 to 110 min = *, 120 to 150 min = ** and 160 to 
240 min = ***). Here the * indicates the p value, the level of significance where, ). *= 
p < 0.05, **= p < 0.01 and ***= p < 0.001 (Fig. 17B). Also DMSO treated Syntaxin 8 
siRNA CTLs, CHX treated control and CHX treated Syntaxin 8 siRNA CTLs showed 
reduced killing. At the initial phase of the killing all these three conditions showed 
similar reduction in killing, but from 180 min onwards, killing by DMSO treated 
Syntaxin 8 downregulated CTLs increases significantly compared to CHX treated 
Syntaxin 8 downregulated CTLs (180 to 240 min = *). Furthermore we found that 
after CHX treatment, the difference between Syntaxin 8 downregulated and control 
CTLs was diminished (Fig. 17B). Thus the recovery in cytotoxicity of DMSO treated 
Syntaxin 8 siRNA CTLs (where CHX mediated inhibition of protein synthesis is 
absent) in the later phase of killing (Fig. 17B) can be due to the effect on some 
processes after protein synthesis like  sorting or trafficking of newly synthesized 
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cytotoxic molecules into releasable lytic granule. However we cannot exclude the 
possibility of Syntaxin 8 influencing the synthesis of new cytotoxic molecules in 
CTLs. 
To rule out the possibility that CHX affects the initial level of cytotoxic proteins, we 
checked the levels of cytotoxic proteins in these transfected CTLs. We found no 
difference in expression levels of perforin and granzyme B in CHX or DMSO treated 
control and Syntaxin 8 down regulated CTLs (Fig. 17C). The Syntaxin 8 
downregulation was also confirmed in these Syntaxin 8 siRNA transfected CTLs (Fig. 
17C). Taken together, these findings indicate that Syntaxin 8 might be involved in 
new protein synthesis but also participates in the sorting and trafficking of cytotoxic 
proteins to the lytic granules.         
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Figure 17: Syntaxin 8 knockdown does not alter the synthesis of cytotoxic molecules. 
(A) Different concentrations of cycloheximide (CHX) were tested for dose dependence on cytotoxicity 
of human CTLs. 10 µg/ml, 30 µg/ml and 100 µg/ml were the concentrations tested. DMSO was used as 
solvent control. (B) SEA stimulated Ctrl- (control) and Stx8-siRNA (Syntaxin 8 siRNA) CTLs were 
incubated with CHX (Ctrl-CHX, Stx8-CHX) or DMSO (Ctrl-DMSO, Stx8-DMSO) for 4 hr at 37
o
C. 
These CTLs were used in real time killing assay at 20:1 effector to target ratio. n = 9, Mean ± SEM. 
There was significant reduction of cytotoxicity between Stx8-DMSO and Ctrl-DMSO from 10 min 
onwards, between Ctrl-DMSO and Ctrl-CHX from 30 min onwards. Even though the cytotoxicity of 
Stx8-DMSO, Ctrl-DMSO and Stx8-CHX were similar initially, the Stx8-DMSO CTLs started to 
recover their cytotoxicity and showed significant difference to Stx8-CHX cytotoxicity from 180 min 
onwards. (C) Western Blot showed downregulation of Stx 8 in both DMSO and CHX treated Stx 8-
siRNA CTLs but all these conditions showed similar initial levels of perforin and granzyme B as the 
DMSO and CHX treated Ctrl-siRNA CTLs. Total number of experiments, n = 3, Mean ± SEM (* P < 
0.05, ** P < 0.01 and *** P < 0.001). 
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3.4.2. Generation of new cytotoxic molecules may be influenced by Syntaxin 8 
To further verify if Syntaxin 8 is involved in synthesis of new cytotoxic proteins, we 
examined after depletion of preexisting lytic granule pool, the change in the 
expression of total perforin protein by Syntaxin 8 down-regulation. As mentioned 
above the preexisting lytic granule pool is released by pre-incubation of the 
transfected CTLs within 96-well plates coated with anti-CD3/anti-CD28 Abs. Then 
the CTLs were recovered for 6 hr in the full medium at 37°C with 5 % CO2. 
Afterwards the CTLs were incubated again with (Ctrl_+Ab, Stx8-+Ab) or without 
(Ctrl_noAb, Stx8_noAb) anti-CD3/anti-CD28 Ab coating and were collected at 
different time points for further preparations. Intracellular perforin was stained and 
the perforin expression was determined with the flow cytometry. IgG2b staining was 
used as an isotype control. We found that these CTLs showed no significant 
difference in the perforin levels in control and Syntaxin 8 downregulated CTLs in 
both conditions, with (Fig. 18B, 18D) and without (Fig. 18A, 18C) release of pre-
existing cytotoxic protein pool. Nevertheless we observed a general tendency of lower 
perforin in Syntaxin 8 downregulated CTLs than in control CTLs in both the 
conditions (Fig. 18D and 18A, 18C). This indicates that the synthesis of new 
cytotoxic proteins may be influenced by Syntaxin 8 which needs to be confirmed by 
further analysis. 
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Figure 18: Perforin expression in Syntaxin 8 downregulated CTLs.Control (Ctrl-siRNA) and 
Syntaxin 8 (Stx8-siRNA) downregulated CTLs were stained for perforin (A) without and (B) with 
releasing the pre-existing pool of cytotoxic molecules after permeabilizing them.  
These CTLs were collected after conjugation with anti-CD3/anti-CD28 Abs (mimicking target cells) at 
different time points [(A) without (Resting, 0.5 hr, 2 hr, 3 hr and overnight) and (B) with release of 
preexisting pool (RestingPP, 2 hr, 3 hr and overnight conjugation)]. Perforin was stained with FITC 
labelled perforin monoclonal Ab and as an isotype control, with FITC Mouse IgG2b Ab (MPC 11 
clone). These stained CTLs were then analysed using a FACS analyzer for the internal perforin 
intensity. (C) The CTLs without releasing the pre-existing pool of cytotoxic molecules and (D) after 
release of the pre-existing pool showed no significant difference in perforin expression but a tendency 
of reduced perforin is observed in Syntaxin 8 downregulated CTLs in both conditions. 
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3.4.3. Syntaxin 8 is required for the regular sorting of cytotoxic molecules into 
lytic granules 
As Syntaxin 8 is mainly localized in late and recycling endosomal compartments (Fig. 
5A, 5D and Fig. 6A, 6D) and as it is indicated to influence the post protein synthesis 
processes according to the CHX treated real time killing assay (Fig. 17B), we 
proceeded to verify if Syntaxin 8 is involved in endosomal pathway, especially the 
sorting of cytotoxic molecules into functional lysosomes (lytic granules). We 
examined the morphology and numbers of lytic granules closely in Syntaxin 8 down-
regulated and control CTLs. Lytic granules were labelled with fluorescence 
conjugated perforin antibody and the total number of perforin vesicles within the 
CTLs and at the IS were counted at various time points for resting (without target 
cells) and conjugated CTLs (30 min, 2 hr, 3 hr, 4 hr and overnight conjugation with 
the target cells) (Fig. 19). The scanned images of these CTLs were partitioned into 3 
parts and the 1/3
rd
 part facing the target cells is defined as the vicinity of the IS (Fig. 
20A), as described before 
45
. We found no significant difference in numbers of 
perforin granules (Fig. 19, 20C) and no change in perforin accumulation at the IS in 
control and Syntaxin 8 downregulated CTLs, no matter in resting or in conjugated 
CTLs (Fig. 19, 20D). However, at 2 hr time point we observed that in Syntaxin 8 
downregulated CTLs the perforin vesicles were larger in size compared to the ones in 
control CTLs (Fig. 19). This was more evident in DMSO treated Syntaxin 8 
downregulated CTLs at 2 hr time point, we observed blob like perforin vesicles (Fig. 
21). Though this was not found in DMSO treated control CTLs or in CHX treated 
control and Syntaxin 8 CTLs (Fig. 21). Furthermore the 3D analysis of the perforin 
vesicles also showed that Syntaxin 8 downregulated CTLs had higher number of 
larger vesicles, compared to the smaller lytic granules in control CTLs at 2 hr (Fig. 
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22B) in contrast to this was the resting condition where Syntaxin 8 downregulated 
CTLs had smaller vesicles (Fig. 22A). This is observed again in the Syntaxin 8 
downregulated CTLs that were pre-incubated with DMSO or CHX and conjugated 
with target cells for 2 hr and stained for perforin. In CHX treated conditions, at both 
resting and 2 hr conjugation (Fig. 21), we observe lesser number of perforin vesicles 
(as expected from the CHX treatment) and they appear to be of similar and smaller in 
size (Fig. 22E, F). Whereas the DMSO treated Syntaxin 8 downregulated CTLs, at 2 
hr time point, showed more of large vesicles, almost double the amount found in 
DMSO treated control CTLs (Fig. 22D). These blob like vesicles were not observed at 
resting condition (Fig. 21, 22C). This phenomenon of larger blob like lytic granules at 
2 hr time point may be due to a sorting problem where the cytotoxic molecules may 
be stuck at the earlier stages of sorting, thus affecting the sorting and delivery of 
perforin (from TGN to early endosomes and then to late endosomes and finally) to the 
lytic granules. This impairment in the sorting of the cytotoxic molecules can slow 
down all the downstream process like trafficking, docking, release of the lytic 
granules and hence the cytotoxicity itself causing much slower rate of killing in 
Syntaxin 8 downregulated CTLs than the control CTLs.  
Another possible explanation for the impairment of CTL cytotoxicity by Syntaxin 8 
downregulation is that Syntaxin 8 downregulated CTLs cannot form a functional 
immunological synapse (IS). Impaired accumulation of TCRs at the IS would be an 
indication for a nonfunctional or defective IS. To examine if the IS formation is 
effected in Syntaxin 8 downregulated CTLs, we checked for TCR accumulation at the 
IS of fixed conjugates. TCR was labelled with fluorescent conjugated anti-CD3 
antibody. The enrichment of TCR was analysed by the relative fluorescence of CD3 at 
the IS, namely 1/3
rd
 proximity to the IS (Fig. 20A). No significant change in the 
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accumulation of TCR at the IS on knockdown of Syntaxin 8 was found at 0.5 hr to 3 
hr as well as overnight (OvN) conjugation with target cells (Fig. 19, 20B). It indicates 
that Syntaxin8 down-regulated CTLs are able to form a functional IS. Though at 4 hr 
after conjugation with target cells, we observed that the total fluorescence of CD3 
measured at the IS in Syntaxin 8 downregulated CTLs increases when compared to 
control CTLs (Fig. 20B). But when we observed the scanned cells we detected that 
among the Syntaxin 8 downregulated CTLs, 66.7 % of CTLs had CD3 accumulated at 
the IS and the rest of 33.3 % of CTLs showed dispersed CD3 at 4 hr time point. Thus 
in Syntaxin 8 downregulated CTLs, the percentage of CTLs that showed CD3 
accumulation at the IS was double than that of CTLs with dispersed CD3 whereas 
among the control CTLs, percentage of CTLs with CD3 at IS and that with dispersed 
CD3 were almost similar and were found to be 51.4 % and 48.6 % respectively at 4 hr 
time point. This can be explained by two hypothesis, one is that, at 4 hr time point, in 
Syntaxin 8 downreguated CTLs, due to the affected endosomal pathway, the recycling 
of the TCR is much slower leading to higher CD3 accumulation at the IS than in the 
control CTLs Another reason could be due to the slower degradation of TCR in these 
CTLs which is caused by less frequent killing events and conjugate formation by 
Syntaxin 8 downregulated CTLs that show reduced cytotoxicity. Hence the more 
active control CTLs degrade their TCR faster than the Syntaxin 8 downregulated 
CTLs which therefore show higher CD3 at the IS at later time points (Fig. 20B). This 
data proves that the IS formation is not impaired on Syntaxin 8 downregulation. All 
these above arguments lead to the conclusion that the formation of a functional IS 
does not depend on Syntaxin 8 but that Syntaxin 8 is essential for the sorting and 
trafficking of lytic granules in CTLs. Therefore Syntaxin 8 downregulation in CTLs, 
impairs and delays the sorting and trafficking of cytotoxic molecules in turn leading 
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to a slower and reduced killing of target cells. Thus Syntaxin 8 affects CTL 
cytotoxicity and is significant for CTL function. 
 
 
Figure 19: Syntaxin 8 downregulation does not affect normal IS formation but impairs the 
sorting and trafficking of lytic granules. 
SEA stimulated control (Ctrl-siRNA) and Syntaxin 8 (Stx8-siRNA) downregulated CTLs were fixed in 
resting (without target / Raji cells) and in conjugation with SEA pulsed Raji cells for different time 
points (30 min or 0.5 hr, 2 hr, 3 hr, 4 hr and overnight) at 37
o
C and immunostained. TCR labelled with 
Alexa
488
 conjugated anti-CD3 Ab (green) accumulated well at the IS in Ctrl and Stx8-siRNA CTLs. 
Lytic granules were labelled with Alexa
647
 conjugated anti-Perforin Ab (red). On 2 hr conjugation with 
target cells, Stx8-siRNA CTLs showed larger perforin vesicles compared to their control CTLs. 
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Figure 20: Syntaxin 8 downregulation doesnot impair normal CD3 and lytic granule 
accumulation at the IS (A) The CTLs were divided into 3 regions and the region closer to the IS and 
the target cell (the 1/3
rd
 region) was analysed for CD3 and perforin accumulation at the IS. (B) The 
total fluorescence of CD3 accumulated at the 1/3
rd
 region near the IS was measured for all the time 
points in conjugated CTLs. (C) The number of perforin vesicles were counted in resting and conjugated 
conditions in the complete CTL (total cell) and (D) also at the IS (1/3
rd
 region of the CTL near the IS). 
Total number of cells, n = 25 to 30 cells for various conditions, Mean ± SEM (p values: * = P < 0.05, 
** = P < 0.01 and *** = P < 0.001). 
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Figure 21: Syntaxin 8 is required for the sorting of the cytotoxic molecules to the lytic granules. 
SEA stimulated control (Ctrl-siRNA) and Syntaxin 8 (Stx8-siRNA) downregulated CTLs were treated 
with CHX or DMSO for 4 hr, at 37
o
C. These CTLs were fixed in resting (without target / Raji cells) 
and in conjugation with SEA pulsed Raji cells for different time points (30 min or 0.5 hr, 2 hr, 3 hr, 4 
hr and overnight) at 37
o
C and immunostained. TCR labelled with Alexa
488
 conjugated anti-CD3 Ab 
(green) accumulated well at the IS in Ctrl and Stx8-siRNA CTLs. Lytic granules were labelled with 
Alexa
647
 conjugated anti-Perforin Ab (red). On 2 hr conjugation with target cells, Stx8-siRNA CTLs 
treated with DMSO showed larger perforin vesicles compared to their control CTLs. 
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Figure 22: Syntaxin 8 downregulation impairs the sorting and trafficking of lytic granules. 
SEA stimulated control (Ctrl-siRNA) and Syntaxin 8 (Stx8-siRNA) downregulated CTLs were fixed in 
resting (without target / Raji cells) and in conjugation with SEA pulsed Raji cells for 2 hr at 37
o
C and 
immunostained. Lytic granules were labelled with Alexa
647
 conjugated anti-Perforin Ab (red). (A) The 
3D volume of the vesicles present in the control and Stx8-siRNA in resting (B) at 2 hr conjugation with 
target cells. (C) Perforin vesicle size measured in Ctrl-siRNA and Stx8-siRNA CTLs treated with 
DMSO in resting condition and (D) at 2 hr of conjugation with target cells. (E) The same was analsed 
for Ctrl-siRNA and Stx8-siRNA CTLs that are treated with CHX (Cycloheximide) during resting and 
(F) at 2 hr of conjugation with target cells. Total number of cells, n = 5 to 10 cells for various 
conditions.
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4. DISCUSSION 
 
In the current study, we have investigated the significance of Syntaxin 8 in the human 
CTL cytotoxicity. Our data show that Syntaxin 8 is prominently localized in the late 
and recycling endosomes, partially colocalizes with lytic granules and Vti1b. 
Downregulation of Syntaxin 8 resulted in reduced CTL cytotoxicity. Syntaxin 8 is not 
involved in the formation of a functional IS, whereas possibly play a role in the 
endosomal trafficking, especially sorting of cytotoxic molecules like perforin into 
lytic granules. These findings reveal previously unknown function of Syntaxin 8 in 
CTLs and further broaden our knowledge on the regulation of CTL cytotoxicity by 
SNARE proteins. In this study, some points remains to be further investigated and 
several new questions emerged, which will be discussed in detail below. 
 
4.1. Syntaxin 8: an important Qc-SNARE in human CTL 
The screening in CTLs has confirmed the expression of different Qa-, Qb-, Qc- and 
R-SNAREs in primary human CTLs 
1
. In the present study, we confirm that in human 
CTLs, Syntaxin 8 accumulates at the IS and that it partially colocalizes with 
functionally significant proteins like CD3 and perforin (Fig. 4A & 4B). We also 
demonstrate that Syntaxin 8 partially colocalizes with Vti1b (Fig. 4C), a Qb- SNARE 
which is required for the tethering of lytic granules to the TCR and thereby docking 
and releasing the lytic granules at the IS. Previous studies have described the 
association of Syntaxin 8 with a Qa- SNARE Syntaxin 7 which is required for the 
accumulation of CD3 at the IS 
98
. We postulate that like in the neuronal cell, Syntaxin 
8 may act as Qc-motif interacting partner for the Qa- Syntaxin 7 in CTLs.  
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4.2. Syntaxin 8 as a player in the endosomal vesicle trafficking pathway 
Earlier studies on Syntaxin 8 protein in different cell types other than human CTLs, 
have shown its involvement at different stages in the endosomal membrane trafficking 
pathway. Syntaxin 8 has been show to be localized in TGN, early endosome and late 
endosomal compartments in NRK, PC12, Cos7, CHO cells 
105,106,110
. In this study, we 
showed that the Syntaxin 8 is localized predominantly in the late endosomes (Fig. 5A, 
6A) and recycling endosomes (Fig. 5D, 6D) in human CTLs both in the presence and 
absence of target cells. We also observed some colocalization between lysosomes and 
Syntaxin 8 (Fig. 5C, 6C). Syntaxin 8 even colocalized with early endosomal 
compartments again in the presence and absence of target cells (Fig. 5B, 6B), though 
the colocalization was not as high as in late endosomes. The localization of Syntaxin 
8 in these endosomal compartments indicates that it might participate in the sorting 
and trafficking of receptors like TCR, FasL and proteins like perforin, granzymes and 
other proteases and hydrolases of the lytic granules. The regulated secretory pathway 
is subdivided into direct and indirect pathways. Proteins with two di-leucine motifs 
participate in both direct and indirect pathways 
108
. Syntaxin 8 has been reported to 
comprise two functionally distinct di-leucine motifs that can independently function, 
suggesting that Syntaxin 8 could participate in both direct and indirect pathways 
109
. 
Syntaxin 8 can be internalized from the plasma membrane by the indirect pathway or 
rather than being transported to the plasma membrane, Syntaxin 8 can be involved in 
the direct pathway by being delivered from the TGN directly to endosomal / 
lysosomal populations and then recycled to endosomes by the plasma membrane 
endosome route 
109
. This can be the reason for Syntaxin 8 localization in early and late 
endosomal and recycling compartments in human CTLs. This is supported by the 
studies showing the localization of Syntaxin 8 (in murine cells and cell lines) in early 
4. Discussion 
 
80 
 
endosomal 
105
, late endosomal compartments 
110
 and also in TGN. The significantly 
higher localization in late and recycling endosomes in CTLs can be an indication of 
the role of Syntaxin 8 in sorting of perforin, granzymes and other proteins to the lytic 
granules through this pathway. What needs to be further studied is the exact role the 
Syntaxin 8 plays in this pathway. Is it responsible for synthesis or transport or 
recycling of lytic granules, CD3 or any other receptors or molecules essential for CTL 
cytotoxicity. We attempt to investigate this further in this study. 
 
4.3. Syntaxin 8 influences cytotoxicity elicited by CTLs 
The siRNA silencing approach facilitated us to efficiently downregulate Syntaxin 8 
(Fig. 7, 8A) in primary human CTLs thus enabling us to analyze its functional 
significance in CTLs. All the experiments were conducted 36 hr after transfection as 
Syntaxin 8 was downregulated at both mRNA and protein levels (Fig. 7C, 7D & 7E) 
and also retaining the effector function of CTLs during this time point. 
Real time killing assay using Calcein dye (Kummerow, C. et al, unpublished) was the 
functional assay used here to measure the CTL cytotoxicity. All the cytotoxicity 
assays shown in this study were conducted with CTLs in AIMV media with 10 % 
FCS except for assays with Ringer solution (Fig. 10) and figures 9B, 11, 12B & 16. 
The reason for this is, the CTLs used in our lab are cultured in AIMV media with 10 
% FCS. To keep the CTLs healthy and comfortable we used this media containing 10 
% FCS, even in the cytotoxicity assays. This worked successfully initially, but with 
the later batches of FCS, we observed that FCS somehow influenced the cytotoxicity 
causing lower efficiency in target lysis. Therefore we tested this assay with AIMV 
media without FCS (Fig. 9B) which showed efficient target lysis. Hence all the 
further cytotoxic assays were conducted using AIMV media without FCS (Fig. 11 & 
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16). The calcium dependency of CTLs for their cytotoxicity was shown by using 
Ringer solutions with different calcium concentrations (Fig. 10). Different 
concentrations of perforin inhibitor conconamycin A (CMA) were used to inhibit 
perforin in CTLs. Cytotoxicity assays conducted with such perforin inhibited CTLs 
showed the dose dependency of the inhibitor and indicated that this cytotoxicity assay 
is more sensitive to perforin mediated killing as the cytotoxicty could be inhibited by 
even a very low concentration (0.5 nM) of CMA. With concentrations lower than 0.5 
nM like 0.25 nM and 0.05 nM, the cytotoxicity is not completely inhibited but was 
reduced compared to the DMSO control. This can be due to either incomplete 
inhibition of all the perforin in CTLs or cyctotoxicity by another pathway called the 
FAS ligand pathway. Thus we conclude that this real time calcein cytotoxicty assay is 
a very sensitive assay which can be used to measure cytotoxicity that is mostly 
mediated by the perforin pathway. 
Measurement of cytotoxicity of Syntaxin 8 downregulated CTLs by this method 
showed a reduction in cytotoxicity in comparison to the control CTLs (Fig. 12A & 
12B). A significant reduction in the cytotoxicity of Syntaxin 8 downregulated CTLs 
was observed from 150 min onwards. This demonstrates that Syntaxin 8 influences 
CTL cytotoxicity. But why do we see a significant reduction only at a later time 
points? One of the reasons for this is that we use SEA stimulated CTLs for 
transfection of the Syntaxin 8 and control siRNAs. As these cells are already activated 
before transfection, both control and Syntaxin 8 downregulated CTLs have similar 
amounts of readily releasable, pre-existing pools of cytotoxic molecules (lytic 
granules). Therefore we hypothesized a more significant downregulation in the 
cytotoxicity of Syntaxin 8 downregulated CTLs, only after the preexisting pool of 
lytic granules is used up. To confirm it, we emptied the preexisting lytic granule pool 
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in both control and Syntaxin 8 downregulated CTLs (after transfection) by stimulating 
them with anti-CD3 / anti-CD28 Ab, which causes exocytosis of the lytic granules. 
After allowing them to recover, these CTLs were measured for their cytotoxicity with 
respect to control and Syntaxin 8 downregulated CTLs that were not emptied of their 
preexisting lytic granule pool. We observed that there is an increase in the difference 
in cytotoxicity of control and Syntaxin 8 downregulated CTLs during the initial time 
points until 100 min but during the later time points the difference in cytotoxicity of 
antibody treated Syntaxin 8 and control CTLs is similar to that of antibody untreated 
CTLs (Fig. 16A & 16B). The reduction in cytotoxicity of Syntaxin 8 downregulated 
CTLs compared to control CTLs established that Syntaxin 8 is crucial for human CTL 
cytotoxicity.  
This is supported by ELISA detection of perforin released by control and Syntaxin 8 
downregulated CTLs that were emptied of their preexisting lytic granule pool by anti-
CD3 / anti-CD28 Ab stimulation. Though the perforin released initially at 8 hr by 
Syntaxin 8 downregulated CTLs was not significantly different than that released by 
control CTLs, from later time points of 16 hr to 48 hr, perforin released by Syntaxin 8 
was significantly lower than the control CTLs. From this, one can deduce that the 
exocytosis of lytic granules maybe impaired in Syntaxin 8 downregulated CTLs. But 
we hold back this theory as the control and Syntaxin 8 downregulated CTLs which are 
not emptied of their preexisting perforin pool (in both conditions where we used Raji 
cells as target cells and CD3 / CD28 activator beads as target cells) showed no 
significant difference in their perforin release till 48 hr. Thus the final exocytosis itself 
is not deterred but some upstream processes prior to the exocytosis are affected by 
Syntaxin 8 downregulation. We cannot check further time points than 48hr, as the 
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Syntaxin 8 siRNA is stable only till this point where it starts to generate the Syntaxin 
8 protein eventually. 
When one observes the cytotoxicity assay data (measured for 4 hr) and the ELISA 
data (measured from 0 hr to 48 hr), there is a difference in the results of the two 
assays. As for the cytotoxicity assay, a difference in the cytotoxicty between Syntaxin 
8 downregulated and control CTLs can be observed within the 4 hr (Fig. 12), whereas 
for ELISA we donot observe a significant difference till 16 hr (Fig. 15) or till 48 hr 
(Fig. 14). For Fig. 15, ELISA assay, the explanation is that as the pre-existing perforin 
pool is emptied, the perforin levels at the beginning of the assay are very low for both 
Syntaxin 8 downregulated and control CTLs making it very sensitive for the assay to 
pick up the difference. So we can only see a significant difference from the next time 
points, which is 16 hr onwards.  
The difference in the results for cytotoxicity assay (Fig. 12) and ELISA assay for 
CTLs without the depletion of pre-existing perforin pool (Fig. 15), might be also due 
to the higher CTL to target ratio used in cytotoxicity assays (0.6 x 10
6
 CTLs to 0.3 x 
10
4
 target cells) as opposed to the lower ratio in the ELISA assays (0.1 x 10
6
 CTLs to 
0.1 x 10
6
 targets) which makes the chance of conjugation with the targets less 
frequent than in the much faster cytotoxicity assay. One must also remember that in 
both the assays (Fig. 12 and Fig. 15) the preexisting cytotoxic molecule pool is not 
emptied, thus in ELISA, due to less frequent conjugate formation, releasable perforin 
level maybe similar in both Syntaxin 8 downregulated and control CTLs and hence 
the difference between the perforin released by both is not significant. Whereas in the 
cytotoxicity assay, as the conjugates formed is more frequent, the release of the pre-
existing perforin is much faster, making the CTLs dependent on newly synthesized 
and sorted cytotoxic molecules. Thus in the cytotoxicity assay, we can observe a 
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difference between the Syntaxin 8 downregulated and control CTLs within 4 hr (Fig. 
12). 
 
4.4. Generation and sorting of cytotoxic molecules to functional lytic granules 
require Syntaxin 8 
We started by examining if Syntaxin 8 downregulation affected the synthesis of new 
cytotoxic molecules, as any impairment in the protein synthesis would result in 
reduced amount of cytotoxic molecules causing reduction in cytotoxicity of the CTLs 
25
. Control and Syntaxin 8 downregulated CTLs that were incubated with a protein 
translocation inhibitor called cycloheximide (CHX) 
135
 were measured for 
cytotoxicity by the real time calcein cytotoxicity assay (Fig. 17B). All these CTLs 
were observed to have similar initial levels of perforin and granzymes (Fig. 17C & 
17D). This is due to the pre-stimulation and activation of both control and Syntaxin 8 
downregulated CTLs by SEA, which leads to the generation of a pre-existing pool of 
cytotoxic molecules. CHX treated control and Syntaxin 8 downregulated CTLs, where 
the new protein synthesis was blocked; showed significantly reduced cytotoxicity 
compared to DMSO treated control CTLs, which have normal protein synthesis 
machinery. DMSO treated Syntaxin 8 downregulated CTLs also showed significantly 
reduced cytotoxicity compared to the DMSO treated control cells. The reduction in 
cytotoxicity of DMSO treated Syntaxin 8 downregulated CTLs, CHX treated control 
and Syntaxin 8 downregulated CTLs were similar in the initial phase of killing but 
from three hours onwards, the DMSO treated Syntaxin 8 downregulated CTLs started 
to regain their cytotoxicity as we see a significant increase in cytotoxicity of DMSO 
treated Syntaxin 8 downregulated CTLs compared to that of CHX treated Syntaxin 8 
downregulated CTLs. This recovery in the cytotoxicity of DMSO treated Syntaxin 8 
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downregulated CTLs in the later phases may suggest that some other upstream 
processes to protein synthesis, such as, sorting and transport of the cytotoxic proteins 
or exocytosis of the lytic granules is affected which causes a delay in the overall 
process of trafficking thus leading to delayed and reduced cytotoxicity. This 
experiment however does not exclude the possibility that Syntaxin 8 may affect the 
synthesis of new cytotoxic proteins, because in Syntaxin 8 DMSO CTLs, due to low 
amount of Syntaxin 8 proteins (by siRNA transfection) in the beginning of the assay 
causes the reduction in cytotoxicity similar to that in CHX treated control and 
Syntaxin 8 downregulated CTLs. But as the protein synthesis is not inhibited in the 
DMSO treated Syntaxin 8 CTLs, some new Syntaxin 8 protein maybe synthesized 
which may aid in the synthesis of new cytotoxic proteins leading to recovery of its 
cytotoxicity to some extent (Fig. 17B), though this is a little farfetched for Syntaxin 8 
protein level in DMSO treated Syntaxin 8 siRNA transfected CTLs to increase within 
4 hr. This is not possible in CHX treated control and Syntaxin 8 CTLs where protein 
synthesis is inhibited, thus maintaining the low Syntaxin 8 protein level in Syntaxin 8 
CHX, eliminating the possibility of proposed Syntaxin 8 influenced synthesis of new 
cytotoxic molecules in CHX treated Syntaxin 8 CTLs. This indicates that Syntaxin 8 
may be involved in the synthesis of cytotoxic molecules. This was further supported 
by intracellular staining of perforin in control and Syntaxin 8 downregulated CTLs 
with and without releasing their pre-existing pool of cytotoxic molecules. FACS 
analysis showed a slightly lower perforin in Syntaxin 8 downregulated CTLs than in 
control CTLs at 0.5 hr in one of the three donors (Fig. 17A) but there was no 
significant difference in the perforin levels in control and Syntaxin 8 downregulated 
CTLs in both the conditions that is, with (Fig. 18B, 18D) and without (Fig. 18A, 18C) 
releasing the pre-existing cytotoxic molecule pool. However we see a tendency of 
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lesser perforin in Syntaxin 8 downregulated CTLs than in control CTLs in both the 
conditions. This indicates that the synthesis of new cytotoxic molecules maybe 
influenced by Syntaxin 8, though this needs to be further elucidated in more donors, 
as the above conclusion is from the results obtained by three donors only. 
The proper sorting and trafficking of cytotoxic molecules into mature releasable lytic 
granules is crucial for CTL cytotoxicity. The signal peptides bound to these cytotoxic 
proteins mark them for sorting into the secretory lysosomes (lytic granules) 
47
. To 
detect if Syntaxin 8 played a role in the vesicle sorting pathway; control and Syntaxin 
8 downregulated CTLs were fixed and stained for perforin and CD3 in both resting 
(no targets) and conjugated (with targets) conditions (Fig. 19) and the fluorescence of 
CD3 at the IS (Fig. 20B) and perforin in total cell area and also at the IS were 
quantified (Fig. 20C, 20D). We did not observe any significant difference in total 
perforin and also perforin vesicles accumulated at the IS between control and 
Syntaxin 8 downregulated CTLs in resting and conjugated conditions (0.5 hr, 2 hr, 3 
hr, 4 hr and overnight time points) (Fig. 20D & 20E). However at 2 hr time point the 
perforin vesicles were larger in size in Syntaxin 8 downregulated CTLs compared to 
that in control CTLs (Fig. 19). The control and Syntaxin 8 downregulated CTLs that 
were treated with CHX showed similar vesicle sizes for resting and 2 hr conjugation 
(Fig.. 21). A prominent difference in size was observed in DMSO treated Syntaxin 8 
downregulated CTLs that showed to have larger perforin vesicles that looked like 
blobs than in DMSO treated control CTLs at 2 hr (Fig. 21). Also the 3D volume 
analysis of perforin vesicles in these resting and 2 hr conjugated CTLs showed that at 
2 hr time point, Syntaxin 8 downregulated CTLs had higher number of larger perforin 
vesicles compared to the smaller vesicles in control CTLs (Fig. 22B, 22D). This 
indicates a sorting problem wherein perforin (from TGN) may not be properly sorted 
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through early and late endosomal compartments to the lytic granules. This impairment 
in the sorting of perforin can rate limit all the downstream process like trafficking, 
docking, release of the lytic granules, thus affecting the cytotoxicity itself by causing 
much slower rate of killing in Syntaxin 8 downregulated CTLs than the control CTLs. 
This causes the control CTLs to be more active than the Syntaxin 8 downregulated 
CTLs. They conjugate with and kill more targets by lytic granule secretion than the 
Syntaxin 8 downregulated CTLs thus leading to the higher cytotoxicity than Syntaxin 
8 downregulated CTLs. 
TCR polarization and the accumulation of TCR at the IS is very crucial for the 
formation of a functional IS 
136
. It has been reported that Vti1b downregulated CTLs 
that showed impaired cytotoxicity did not show any impairment in MTOC and Golgi 
polarization to the IS 
45
 (Fig. 23). This and the other important feature of normal CD3 
accumulation at the IS proved the formation of a functional IS by Vti1b 
downregulated CTLs 
45
. 
 
 
 
 
 
Figure 23: MTOC and Golgi polarization not impaired on Vti1b downregulation 
The polarization machinery is unaltered in Vti1b downregulated CTLs despite their impaired 
cytotoxicity. MTOC was labelled with γ-tubulin GFP and trans-Golgi was labelled with GM 130 
mouse monoclonal primary antibody and Alexa
568
 conjugated secondary goat anti-rabbit Ab (red). 
Scale bar = 3 µm. 
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CTLs. Similar accumulation of CD3 at the IS was observed in Syntaxin 8 
downregulated and control CTL during initial time points of 0.5 hr to 3 hr conjugation 
with targets. However at 4 hr, CD3 accumulation at the IS was higher in Syntaxin 8 
downregulated CTLs than in controls (Fig. 20, 21B). On overnight conjugation, CD3 
accumulation was again similar and limited in both Syntaxin 8 and control CTLs (Fig. 
21B). One should note that at 4 hr not only was the CD3 accumulation more in 
Syntaxin 8 downregulated CTLs but the percentage of Syntaxin 8 downregulated 
CTLs with CD3 accumulated at the IS was double the percentage of cells with CD3 
distributed throughout the cell. That is, we observed 66.7 % of Syntaxin 8 
downregulated CTLs with CD3 at the IS and 33.3 % of them with dispersed CD3, 
This was not the case in control CTLs were the percentage of cells with CD3 at the IS 
(51.4 % CTLs) and that of cells with overall distributed CD3 (48.6 % CTLs) were 
almost similar. This shows that even though there is CD3 throughout the area of CTLs 
in both Syntaxin 8 and control CTLs, the accumulation at the IS is significantly higher 
in Syntaxin 8 downregulated CTLs than in control CTLs at 4 hr conjugation (Fig. 
20B). The Syntaxin 8 downregulated CTLs showed higher CD3 accumulation at 4 hr 
than in control CTLs because Syntaxin 8 that is localized in early endosomes and 
mostly in the late endosomes and recycling endosomes, when downregulated, could 
limit the recycling of TCR from the IS to the early, then to late endosomes and finally 
either back to the plasma membrane or to lysosomes for degradation. Thus retaining 
more CD3 at the IS than the control CTLs at 4 hr time point. It is also possible that the 
impairment in sorting of perforin to the lytic granules causes the reduced cytotoxicity 
of Syntaxin 8 downregulated CTLs due to slower and lesser release of perforin 
compared to the control CTLs. Hence the more active control CTLs might degrade 
their TCR faster than the much slower Syntaxin 8 downregulated CTLs which could 
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in turn show higher CD3 at the IS at later time points. But on overnight conjugation, 
the Syntaxin 8 downregulated CTLs start recovering their Syntaxin 8 protein leading 
to faster recycling or degrading of the TCR. Another reason could be that the active 
control CTLs start generating and expressing new CD3 whereas the CD3 in Syntaxin 
8 downregulated CTLs start recycling and also degrading thus showing similar CD3 
accumulation at the IS as the control CTLs for overnight time point. Thus we could 
show that Syntaxin 8 downregulation does not impair the IS formation but could 
affect the CD3 endocytic pathway and by the likely participation of Syntaxin 8 in the 
sorting and trafficking of perforin, its downregulation leads to the delay and thus 
impairment of CTL cytotoxicity. 
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5. OUTLOOK 
 
Our study proved that Syntaxin 8 is essential for CTL cytotoxicty and that it is 
involved in the endosomal pathway by influencing the sorting and trafficking of 
cytotoxic molecules like perforin to the lytic granules. It might also affect the 
generation of cytotoxic molecules, though this needs to be confirmed by further 
analysis. The actual stage in the endosomal trafficking pathway that the Syntaxin 8 is 
involved can be examined further. One can use electron microscopy to identify the 
endosomal compartment the perforin vesicles or lytic granules are trapped in at 2 hr 
conjugation of CTLs with target cells. Also as Syntaxin 8 siRNA only downregulates 
the protein, one can get a more efficient phenotype in a knockout mice which may 
give us more insights into the Syntaxin 8 function in CTLs. Syntaxin 8 has been 
reported to be one of the interacting partners in the SNARE complex formed by 
Vti1b, Syntaxin 7 and VAMP7 in cells other than CTLs like neuronal and NRK cells 
111-113
. It has been shown that in human CTLs, Syntaxin 8 co-immunoprecipitates with 
Syntaxin 7 
98
 suggesting that they may be interacting partners. It would be very 
interesting to determine which Qa-, Qb- and R- SNAREs interact with Syntaxin 8 if 
forming a SNARE complex in human CTLs. It would also be useful to examine if 
Syntaxin 8 interacted with or compensated for any proteins involved in the 
functioning of CTLs. 
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6. SUMMARY  
 
By the results observed and discussed we can conclude that Syntaxin 8 is significant 
for the cytotoxicity in human CTLs. On efficiently downregulating Syntaxin 8 in 
human CTLs we observed that they influence cytotoxicity not by affecting the 
exocytosis itself but by affecting some stages prior to exocytosis. The reason for this 
could be due to the effect in generation and more importantly by delay in the sorting 
and trafficking of cytotoxic molecules into readily releasable lytic granules to the IS 
of the CTLs. It is indicated that Syntaxin 8 participates in the endosomal trafficking 
pathway as it colocalizes with early (partial), late, recycling and lysosomal 
compartments but predominantly with late and recycling endosomes. On 2 hr 
conjugation with target cells, Syntaxin 8 downregulated CTLs showed larger blob like 
perforin vesicles than control CTLs, indicating that perforin might be trapped in the 
early phase of trafficking probably in the trans-Gogli. This delay in sorting and 
trafficking in Syntaxin 8 downregulated CTLs, may cause the lytic granules to reach 
the IS and in turn get released at the IS very slowly compared to that in control CTLs. 
This also affects the CD3 (TCR) accumulation at the IS, at later time points. Thus the 
slower cytotoxic machinery in the Syntaxin 8 downregulated CTLs may lead to 
slower degradation of TCRs than in control CTLs, at longer time points. Also the 
recycling of TCR to the plasma membrane maybe slower in Syntaxin 8 
downregulated CTLs, though the IS formation is not impaired in Syntaxin 8 
downregulated CTLs. Thus Syntaxin 8 downregulated CTLs form normal conjugates 
with the targets but have delayed sorting and trafficking of cytotoxic molecules into 
readily releasable lytic granules, affecting the CTL cytotoxicity. 
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